<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T08:52:08Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:3251561" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:3251561</identifier>
        <datestamp>2012-01-11</datestamp>
        <setSpec>plosone</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
              <journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id>
              <journal-id journal-id-type="publisher-id">plos</journal-id>
              <journal-id journal-id-type="pmc">plosone</journal-id>
              <journal-title-group>
                <journal-title>PLoS ONE</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1932-6203</issn>
              <publisher>
                <publisher-name>Public Library of Science</publisher-name>
                <publisher-loc>San Francisco, USA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC3251561</article-id>
              <article-id pub-id-type="pmcid">PMC3251561</article-id>
              <article-id pub-id-type="pmc-uid">3251561</article-id>
              <article-id pub-id-type="pmid">22238577</article-id>
              <article-id pub-id-type="pmid">22238577</article-id>
              <article-id pub-id-type="publisher-id">PONE-D-11-12659</article-id>
              <article-id pub-id-type="doi">10.1371/journal.pone.0028370</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="Discipline-v2">
                  <subject>Biology</subject>
                  <subj-group>
                    <subject>Biochemistry</subject>
                    <subj-group>
                      <subject>Chemical Biology</subject>
                      <subject>Proteins</subject>
                    </subj-group>
                  </subj-group>
                  <subj-group>
                    <subject>Neuroscience</subject>
                    <subj-group>
                      <subject>Behavioral Neuroscience</subject>
                      <subject>Neuropsychology</subject>
                      <subject>Neurotransmitters</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v2">
                  <subject>Medicine</subject>
                  <subj-group>
                    <subject>Drugs and Devices</subject>
                    <subj-group>
                      <subject>Behavioral Pharmacology</subject>
                      <subject>Clinical Pharmacology</subject>
                      <subject>Drug Information</subject>
                      <subject>Neuropharmacology</subject>
                    </subj-group>
                  </subj-group>
                  <subj-group>
                    <subject>Mental Health</subject>
                    <subj-group>
                      <subject>Psychiatry</subject>
                      <subj-group>
                        <subject>Mood Disorders</subject>
                        <subject>Substance Abuse</subject>
                      </subj-group>
                    </subj-group>
                    <subj-group>
                      <subject>Psychology</subject>
                      <subj-group>
                        <subject>Behavior</subject>
                        <subj-group>
                          <subject>Emotions</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>The Dopamine Augmenter L-DOPA Does Not Affect Positive Mood in Healthy Human Volunteers</article-title>
                <alt-title alt-title-type="running-head">L-DOPA and Mood</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Liggins</surname>
                    <given-names>John</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Pihl</surname>
                    <given-names>Robert O.</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Benkelfat</surname>
                    <given-names>Chawki</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Leyton</surname>
                    <given-names>Marco</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1"/>
                  <xref ref-type="corresp" rid="cor1">
                    <sup>*</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="aff1">
                <addr-line>Department of Psychiatry, McGill University, Montréal, Québec, Canada</addr-line>
              </aff>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Le Foll</surname>
                    <given-names>Bernard</given-names>
                  </name>
                  <role>Editor</role>
                  <xref ref-type="aff" rid="edit1"/>
                </contrib>
              </contrib-group>
              <aff id="edit1">Centre for Addiction and Mental Health, Canada</aff>
              <author-notes>
                <corresp id="cor1">* E-mail: <email>marco.leyton@mcgill.ca</email></corresp>
                <fn fn-type="con">
                  <p>Conceived and designed the experiments: ML RP. Performed the experiments: JL ML CB. Analyzed the data: JL. Wrote the paper: JL ML. Revising manuscript for intellectual content: CB RP ML.</p>
                </fn>
              </author-notes>
              <pub-date pub-type="collection">
                <year>2012</year>
              </pub-date>
              <pub-date pub-type="epub">
                <day>4</day>
                <month>1</month>
                <year>2012</year>
              </pub-date>
              <volume>7</volume>
              <issue>1</issue>
              <elocation-id>e28370</elocation-id>
              <history>
                <date date-type="received">
                  <day>1</day>
                  <month>7</month>
                  <year>2011</year>
                </date>
                <date date-type="accepted">
                  <day>7</day>
                  <month>11</month>
                  <year>2011</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>Liggins et al.</copyright-statement>
                <copyright-year>2012</copyright-year>
                <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
                  <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p>
                </license>
              </permissions>
              <abstract>
                <p>Dopamine neurotransmission influences approach toward rewards and reward-related cues. The best cited interpretation of this effect proposes that dopamine mediates the pleasure that commonly accompanies reward. This hypothesis has received support in some animal models and a few studies in humans. However, direct assessments of the effect of transiently increasing dopamine neurotransmission have been largely limited to the use of psychostimulant drugs, which elevate brain levels of multiple neurotransmitters in addition to dopamine. In the present study we tested the effect of more selectively elevating dopamine neurotransmission, as produced by administration of the immediate dopamine precursor, L-DOPA (0, 100/25, 200/50 mg, Sinemet), in healthy human volunteers. Neither dose altered positive mood. The results suggest that dopamine neurotransmission does not directly influence positive mood in humans.</p>
              </abstract>
              <counts>
                <page-count count="6"/>
              </counts>
            </article-meta>
          </front>
          <body>
            <sec id="s1">
              <title>Introduction</title>
              <p>Mesolimbic dopamine (DA) neurotransmission influences the ability of rewards to elicit focused interest and approach <xref rid="pone.0028370-Wise1" ref-type="bibr">[1]</xref>–<xref rid="pone.0028370-Stewart1" ref-type="bibr">[5]</xref>. One early and still frequently cited interpretation is that the transmitter mediates pleasure <xref rid="pone.0028370-Wise2" ref-type="bibr">[6]</xref>. This possibility was first suggested following observations that neuroleptic medications decreased amphetamine-induced subjective “high” in stimulant drug abusers <xref rid="pone.0028370-Gunne1" ref-type="bibr">[7]</xref>–<xref rid="pone.0028370-Jonsson2" ref-type="bibr">[9]</xref> and produced a sense of “psychic indifference” in patients with schizophrenia <xref rid="pone.0028370-Singh1" ref-type="bibr">[10]</xref> while extended treatment with high doses of L-DOPA led to hypomanic states in patients with bipolar mood disorders <xref rid="pone.0028370-Murphy1" ref-type="bibr">[11]</xref>. Subsequently, a series of carefully controlled and influential animal studies indicated that increases in DA neurotransmission augmented instrumental responding for electrical stimulation of the brain (ESB) <xref rid="pone.0028370-Phillips2" ref-type="bibr">[12]</xref> while decreased DA neurotransmission disrupted responding for drugs, food, and ESB <xref rid="pone.0028370-Fouriezos1" ref-type="bibr">[13]</xref>–<xref rid="pone.0028370-Yokel2" ref-type="bibr">[18]</xref>. The latter effects were not attributable to compromised motor function since low doses of DA receptor antagonists increased instrumental responding while higher doses produced biphasic increases and decreases. These observations led to the suggestion that DA receptor antagonists reduced the ability to experience pleasure <xref rid="pone.0028370-Wise2" ref-type="bibr">[6]</xref>.</p>
              <p>Some recent work is at least consistent with the anhedonia hypothesis. For example, individual differences in the magnitude of drug-induced striatal DA responses correlate with approach-related personality traits <xref rid="pone.0028370-Leyton1" ref-type="bibr">[19]</xref>–<xref rid="pone.0028370-Buckholtz2" ref-type="bibr">[22]</xref> and the substance's positive subjective effects <xref rid="pone.0028370-Oswald1" ref-type="bibr">[23]</xref>–<xref rid="pone.0028370-Volkow1" ref-type="bibr">[31]</xref>. In the converse experiments, mood-lowering effects of antipsychotic medications are predicted by their extent of DA D2 receptor blockade <xref rid="pone.0028370-Bressan1" ref-type="bibr">[32]</xref>–<xref rid="pone.0028370-Mizrahi1" ref-type="bibr">[34]</xref>.</p>
              <p>Other work, though, has seemed inconsistent with a role of DA in pleasure. First, in both humans <xref rid="pone.0028370-Pruessner1" ref-type="bibr">[35]</xref>, <xref rid="pone.0028370-Scott1" ref-type="bibr">[36]</xref> and in laboratory animals <xref rid="pone.0028370-Ikemoto1" ref-type="bibr">[3]</xref>, <xref rid="pone.0028370-Salamone1" ref-type="bibr">[37]</xref> DA release in the ventral striatum can also be evoked by aversive stimuli. Second, in operant conditioning paradigms, DA release increases and then peaks just prior to a lever press for reward and then gradually decreases thereafter <xref rid="pone.0028370-Gratton1" ref-type="bibr">[38]</xref>, <xref rid="pone.0028370-Kiyatkin1" ref-type="bibr">[39]</xref>. With experience DA comes to be released in response to cues associated with the reward <xref rid="pone.0028370-Gratton1" ref-type="bibr">[38]</xref>–<xref rid="pone.0028370-Schultz1" ref-type="bibr">[40]</xref> but not when actually receiving the reward <xref rid="pone.0028370-Schultz1" ref-type="bibr">[40]</xref>, <xref rid="pone.0028370-Gratton2" ref-type="bibr">[41]</xref>. Third, an extensive series of studies has indicated that neither DA antagonists nor DA lesions alter responses in the ‘taste reactivity’ paradigm, an animal model of eating-related pleasure <xref rid="pone.0028370-Berridge1" ref-type="bibr">[2]</xref>, <xref rid="pone.0028370-Berridge2" ref-type="bibr">[42]</xref>, <xref rid="pone.0028370-Berridge3" ref-type="bibr">[43]</xref>. Finally, the majority of studies have failed to replicate an ability of neuroleptic medications or other DA lowering manipulations to decrease drug-induced pleasure in humans <xref rid="pone.0028370-Romach1" ref-type="bibr">[44]</xref>–<xref rid="pone.0028370-Venugopalan1" ref-type="bibr">[58]</xref>.</p>
              <p>Given the above controversies, the present study aimed to test the effect of a more selective DA augmenter, L-DOPA, on mood states in healthy human volunteers. Since individual differences in approach-related traits predict differences in DA reactivity, it was further hypothesized that those who scored higher on these traits would exhibit greater mood elevation.</p>
            </sec>
            <sec id="s2">
              <title>Results</title>
              <p>There were no significant Group x Time interaction effects for any of the POMS subscales (all ps&gt;0.05, see <xref ref-type="table" rid="pone-0028370-t001">Table 1</xref>), nor were there significant main effects of personality (all ps&gt;0.05). A three-way Group x Personality subgroup x Time interaction raised the possibility that NS2 predicted differential POMS Agreeable-Hostile responses to L-DOPA, but this effect was no longer significant when VAS “Nauseous” scores were entered as covariates (F<sub>6, 114</sub> = 0.804, p&gt;0.05). Effects on nausea were mild (peak change = 1.4/10), and statistically significant for the 200 mg L-DOPA dose only (F<sub>6, 126</sub> = 2.839, p&lt;0.05) (see <xref ref-type="table" rid="pone-0028370-t001">Table 1</xref>).</p>
              <table-wrap id="pone-0028370-t001" position="float">
                <object-id pub-id-type="doi">10.1371/journal.pone.0028370.t001</object-id>
                <label>Table 1</label>
                <caption>
                  <title>Effect of L-DOPA on mood and nausea.</title>
                </caption>
                <alternatives>
                  <graphic id="pone-0028370-t001-1" xlink:href="pone.0028370.t001"/>
                  <table frame="hsides" rules="groups">
                    <colgroup span="1">
                      <col align="left" span="1"/>
                      <col align="center" span="1"/>
                      <col align="center" span="1"/>
                      <col align="center" span="1"/>
                      <col align="center" span="1"/>
                      <col align="center" span="1"/>
                      <col align="center" span="1"/>
                    </colgroup>
                    <thead>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">POMS Item</td>
                        <td align="left" rowspan="1" colspan="1">Group</td>
                        <td align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">T2</td>
                        <td align="left" rowspan="1" colspan="1">T3</td>
                        <td align="left" rowspan="1" colspan="1">T4</td>
                        <td align="left" rowspan="1" colspan="1">Peak Change</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">(+45 mins.)</td>
                        <td align="left" rowspan="1" colspan="1">(+105 mins.)</td>
                        <td align="left" rowspan="1" colspan="1">(+165 mins.)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Composed-Anxious</td>
                        <td align="left" rowspan="1" colspan="1">Placebo</td>
                        <td align="left" rowspan="1" colspan="1">60.1±1.9</td>
                        <td align="left" rowspan="1" colspan="1">61.6±1.7</td>
                        <td align="left" rowspan="1" colspan="1">60.3±1.6</td>
                        <td align="left" rowspan="1" colspan="1">60.1±1.8</td>
                        <td align="left" rowspan="1" colspan="1">− 1.0±2.4</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">100 mg L-DOPA</td>
                        <td align="left" rowspan="1" colspan="1">57.4±2.6</td>
                        <td align="left" rowspan="1" colspan="1">58.9±2.3</td>
                        <td align="left" rowspan="1" colspan="1">57.7±2.4</td>
                        <td align="left" rowspan="1" colspan="1">58.1±2.2</td>
                        <td align="left" rowspan="1" colspan="1">0.19±2.8</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">200 mg L-DOPA</td>
                        <td align="left" rowspan="1" colspan="1">56.7±2.0</td>
                        <td align="left" rowspan="1" colspan="1">58.6±2.0</td>
                        <td align="left" rowspan="1" colspan="1">55.8±2.1</td>
                        <td align="left" rowspan="1" colspan="1">57.3±2.2</td>
                        <td align="left" rowspan="1" colspan="1">0.63±2.0</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Elated-Depressed</td>
                        <td align="left" rowspan="1" colspan="1">Placebo</td>
                        <td align="left" rowspan="1" colspan="1">54.7±1.4</td>
                        <td align="left" rowspan="1" colspan="1">54.2±1.4</td>
                        <td align="left" rowspan="1" colspan="1">58.1±1.7</td>
                        <td align="left" rowspan="1" colspan="1">55.1±1.6</td>
                        <td align="left" rowspan="1" colspan="1">2.1±1.7</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">100 mg L-DOPA</td>
                        <td align="left" rowspan="1" colspan="1">54.0±1.8</td>
                        <td align="left" rowspan="1" colspan="1">53.8±1.4</td>
                        <td align="left" rowspan="1" colspan="1">54.1±2.0</td>
                        <td align="left" rowspan="1" colspan="1">52.0±1.9</td>
                        <td align="left" rowspan="1" colspan="1">− 0.75±1.2</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">200 mg L-DOPA</td>
                        <td align="left" rowspan="1" colspan="1">55.8±1.9</td>
                        <td align="left" rowspan="1" colspan="1">53.7±1.5</td>
                        <td align="left" rowspan="1" colspan="1">56.6±1.6</td>
                        <td align="left" rowspan="1" colspan="1">53.8±1.7</td>
                        <td align="left" rowspan="1" colspan="1">− 2.0±1.6</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Energetic-Tired</td>
                        <td align="left" rowspan="1" colspan="1">Placebo</td>
                        <td align="left" rowspan="1" colspan="1">51.6±1.4</td>
                        <td align="left" rowspan="1" colspan="1">49.4±1.6</td>
                        <td align="left" rowspan="1" colspan="1">56.1±1.8</td>
                        <td align="left" rowspan="1" colspan="1">53.3±1.4</td>
                        <td align="left" rowspan="1" colspan="1">0.63±2.6</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">100 mg L-DOPA</td>
                        <td align="left" rowspan="1" colspan="1">55.1±2.0</td>
                        <td align="left" rowspan="1" colspan="1">51.0±2.1</td>
                        <td align="left" rowspan="1" colspan="1">53.6±2.4</td>
                        <td align="left" rowspan="1" colspan="1">52.0±2.5</td>
                        <td align="left" rowspan="1" colspan="1">− 5.0±2.2</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">200 mg L-DOPA</td>
                        <td align="left" rowspan="1" colspan="1">54.2±1.7</td>
                        <td align="left" rowspan="1" colspan="1">47.8±1.9</td>
                        <td align="left" rowspan="1" colspan="1">51.6±2.0</td>
                        <td align="left" rowspan="1" colspan="1">49.9±1.9</td>
                        <td align="left" rowspan="1" colspan="1">− 6.7±1.8</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Agreeable-Hostile</td>
                        <td align="left" rowspan="1" colspan="1">Placebo</td>
                        <td align="left" rowspan="1" colspan="1">55.6±1.8</td>
                        <td align="left" rowspan="1" colspan="1">54.7±1.9</td>
                        <td align="left" rowspan="1" colspan="1">56.3±1.9</td>
                        <td align="left" rowspan="1" colspan="1">53.8±1.4</td>
                        <td align="left" rowspan="1" colspan="1">− 2.3±1.8</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">100 mg L-DOPA</td>
                        <td align="left" rowspan="1" colspan="1">53.3±2.4</td>
                        <td align="left" rowspan="1" colspan="1">53.2±2.2</td>
                        <td align="left" rowspan="1" colspan="1">54.2±2.6</td>
                        <td align="left" rowspan="1" colspan="1">53.7±2.4</td>
                        <td align="left" rowspan="1" colspan="1">0.0±1.4</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">200 mg L-DOPA</td>
                        <td align="left" rowspan="1" colspan="1">52.1±1.5</td>
                        <td align="left" rowspan="1" colspan="1">50.6±1.7</td>
                        <td align="left" rowspan="1" colspan="1">51.4±1.6</td>
                        <td align="left" rowspan="1" colspan="1">50.1±1.9</td>
                        <td align="left" rowspan="1" colspan="1">− 2.5±1.6</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Confident-Unsure</td>
                        <td align="left" rowspan="1" colspan="1">Placebo</td>
                        <td align="left" rowspan="1" colspan="1">55.2±1.3</td>
                        <td align="left" rowspan="1" colspan="1">54.2±1.6</td>
                        <td align="left" rowspan="1" colspan="1">56.7±1.5</td>
                        <td align="left" rowspan="1" colspan="1">54.8±1.5</td>
                        <td align="left" rowspan="1" colspan="1">− 0.69±1.2</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">100 mg L-DOPA</td>
                        <td align="left" rowspan="1" colspan="1">55.8±1.5</td>
                        <td align="left" rowspan="1" colspan="1">54.4±1.6</td>
                        <td align="left" rowspan="1" colspan="1">54.8±1.8</td>
                        <td align="left" rowspan="1" colspan="1">54.6±1.7</td>
                        <td align="left" rowspan="1" colspan="1">− 1.9±1.5</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">200 mg L-DOPA</td>
                        <td align="left" rowspan="1" colspan="1">53.6±1.7</td>
                        <td align="left" rowspan="1" colspan="1">52.2±1.8</td>
                        <td align="left" rowspan="1" colspan="1">53.0±2.1</td>
                        <td align="left" rowspan="1" colspan="1">52.9±1.7</td>
                        <td align="left" rowspan="1" colspan="1">− 0.75±1.4</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Clearheaded-Confused</td>
                        <td align="left" rowspan="1" colspan="1">Placebo</td>
                        <td align="left" rowspan="1" colspan="1">57.0±1.7</td>
                        <td align="left" rowspan="1" colspan="1">55.4±1.6</td>
                        <td align="left" rowspan="1" colspan="1">58.4±1.6</td>
                        <td align="left" rowspan="1" colspan="1">56.4±1.6</td>
                        <td align="left" rowspan="1" colspan="1">− 1.3±2.4</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">100 mg L-DOPA</td>
                        <td align="left" rowspan="1" colspan="1">56.6±1.7</td>
                        <td align="left" rowspan="1" colspan="1">54.8±1.7</td>
                        <td align="left" rowspan="1" colspan="1">55.6±1.8</td>
                        <td align="left" rowspan="1" colspan="1">55.1±2.0</td>
                        <td align="left" rowspan="1" colspan="1">− 0.81±2.3</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">200 mg L-DOPA</td>
                        <td align="left" rowspan="1" colspan="1">55.0±1.7</td>
                        <td align="left" rowspan="1" colspan="1">52.4±2.5</td>
                        <td align="left" rowspan="1" colspan="1">53.4±2.2</td>
                        <td align="left" rowspan="1" colspan="1">52.7±2.3</td>
                        <td align="left" rowspan="1" colspan="1">− 3.3±1.3</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>VAS Item</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Nauseous</td>
                        <td align="left" rowspan="1" colspan="1">Placebo</td>
                        <td align="left" rowspan="1" colspan="1">1.8±0.23</td>
                        <td align="left" rowspan="1" colspan="1">2.2±0.37</td>
                        <td align="left" rowspan="1" colspan="1">1.4±0.16</td>
                        <td align="left" rowspan="1" colspan="1">1.4±0.15</td>
                        <td align="left" rowspan="1" colspan="1">0.25±0.47</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">100 mg L-DOPA</td>
                        <td align="left" rowspan="1" colspan="1">1.6±0.22</td>
                        <td align="left" rowspan="1" colspan="1">1.4±0.22</td>
                        <td align="left" rowspan="1" colspan="1">1.3±0.17</td>
                        <td align="left" rowspan="1" colspan="1">1.4±0.31</td>
                        <td align="left" rowspan="1" colspan="1">− 0.13±0.36</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">200 mg L-DOPA</td>
                        <td align="left" rowspan="1" colspan="1">1.5±0.18</td>
                        <td align="left" rowspan="1" colspan="1">2.0±0.27</td>
                        <td align="left" rowspan="1" colspan="1">1.9±0.39</td>
                        <td align="left" rowspan="1" colspan="1">2.6±0.54 <sup>A, B, C</sup>
</td>
                        <td align="left" rowspan="1" colspan="1">1.4±0.52</td>
                      </tr>
                    </tbody>
                  </table>
                </alternatives>
                <table-wrap-foot>
                  <fn id="nt101">
                    <label/>
                    <p>(Means±SEM).</p>
                  </fn>
                  <fn id="nt102">
                    <label/>
                    <p>A = significantly different from placebo, B = significantly different from baseline, p&lt;0.05, C = significantly different from 100 mg L-DOPA group at T4.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
            </sec>
            <sec id="s3">
              <title>Discussion</title>
              <p>In the present study, the immediate DA precursor, L-DOPA, did not affect positive subjective states in healthy human volunteers, neither in the groups as a whole nor in subgroups based on hypothesized DA-related personality traits. These findings extend the results from previous drug challenge studies. In contrast to non-specific DA augmenters, such as psychostimulant drugs, which reliably and potently elevate mood in healthy human volunteers <xref rid="pone.0028370-Volkow1" ref-type="bibr">[31]</xref>, <xref rid="pone.0028370-Barrett1" ref-type="bibr">[53]</xref>, <xref rid="pone.0028370-Acheson1" ref-type="bibr">[59]</xref>–<xref rid="pone.0028370-Hamidovic1" ref-type="bibr">[61]</xref>, accumulating evidence indicates that more selective DA receptor agonists do not (<xref ref-type="table" rid="pone-0028370-t002">Table 2</xref>).</p>
              <table-wrap id="pone-0028370-t002" position="float">
                <object-id pub-id-type="doi">10.1371/journal.pone.0028370.t002</object-id>
                <label>Table 2</label>
                <caption>
                  <title>The effect of dopamine-enhancing agents on positive mood states in healthy humans.</title>
                </caption>
                <alternatives>
                  <graphic id="pone-0028370-t002-2" xlink:href="pone.0028370.t002"/>
                  <table frame="hsides" rules="groups">
                    <colgroup span="1">
                      <col align="left" span="1"/>
                      <col align="center" span="1"/>
                      <col align="center" span="1"/>
                      <col align="center" span="1"/>
                      <col align="center" span="1"/>
                      <col align="center" span="1"/>
                      <col align="center" span="1"/>
                      <col align="center" span="1"/>
                    </colgroup>
                    <thead>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Drug</td>
                        <td align="left" rowspan="1" colspan="1">Mechanism of</td>
                        <td align="left" rowspan="1" colspan="1">Dose</td>
                        <td align="left" rowspan="1" colspan="1">Study</td>
                        <td align="left" rowspan="1" colspan="1">n</td>
                        <td align="left" rowspan="1" colspan="1">Mood</td>
                        <td align="left" rowspan="1" colspan="1">Effect on</td>
                        <td align="left" rowspan="1" colspan="1">Details</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">Action</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">Measures</td>
                        <td align="left" rowspan="1" colspan="1">Positive Mood</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Apomorphine</td>
                        <td align="left" rowspan="1" colspan="1">Mixed D1/D2</td>
                        <td align="left" rowspan="1" colspan="1">10 µg/kg, s.c.</td>
                        <td align="left" rowspan="1" colspan="1">
                          <xref rid="pone.0028370-Blin1" ref-type="bibr">[95]</xref>
                        </td>
                        <td align="left" rowspan="1" colspan="1">9</td>
                        <td align="left" rowspan="1" colspan="1">VAS</td>
                        <td align="left" rowspan="1" colspan="1">0</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">agonist</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Bromocriptine</td>
                        <td align="left" rowspan="1" colspan="1">D2 agonist</td>
                        <td align="left" rowspan="1" colspan="1">1.25 mg, p.o.</td>
                        <td align="left" rowspan="1" colspan="1">
                          <xref rid="pone.0028370-Morcom1" ref-type="bibr">[96]</xref>
                        </td>
                        <td align="left" rowspan="1" colspan="1">32</td>
                        <td align="left" rowspan="1" colspan="1">VAS</td>
                        <td align="left" rowspan="1" colspan="1">NR</td>
                        <td align="left" rowspan="1" colspan="1">VAS items corresponding to motivation and energy</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">2.5 mg, p.o.</td>
                        <td align="left" rowspan="1" colspan="1">
                          <xref rid="pone.0028370-Micallef1" ref-type="bibr">[97]</xref>
                        </td>
                        <td align="left" rowspan="1" colspan="1">12</td>
                        <td align="left" rowspan="1" colspan="1">VAS</td>
                        <td align="left" rowspan="1" colspan="1">0</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">2.5 mg, p.o.</td>
                        <td align="left" rowspan="1" colspan="1">
                          <xref rid="pone.0028370-Franken1" ref-type="bibr">[98]</xref>
                        </td>
                        <td align="left" rowspan="1" colspan="1">21</td>
                        <td align="left" rowspan="1" colspan="1">VAS</td>
                        <td align="left" rowspan="1" colspan="1">0</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">1.25 mg, p.o.</td>
                        <td align="left" rowspan="1" colspan="1">
                          <xref rid="pone.0028370-Cools1" ref-type="bibr">[99]</xref>
                        </td>
                        <td align="left" rowspan="1" colspan="1">22</td>
                        <td align="left" rowspan="1" colspan="1">VAS</td>
                        <td align="left" rowspan="1" colspan="1">0</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">2.5 mg, p.o.</td>
                        <td align="left" rowspan="1" colspan="1">
                          <xref rid="pone.0028370-RoeschEly1" ref-type="bibr">[100]</xref>
                        </td>
                        <td align="left" rowspan="1" colspan="1">40</td>
                        <td align="left" rowspan="1" colspan="1">AMS</td>
                        <td align="left" rowspan="1" colspan="1">0</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">1.25 mg, p.o.</td>
                        <td align="left" rowspan="1" colspan="1">
                          <xref rid="pone.0028370-Mehta1" ref-type="bibr">[101]</xref>
                        </td>
                        <td align="left" rowspan="1" colspan="1">20</td>
                        <td align="left" rowspan="1" colspan="1">VAS</td>
                        <td align="left" rowspan="1" colspan="1">↓</td>
                        <td align="left" rowspan="1" colspan="1">Bromocriptine ↓ VAS Contented and ↑ VAS Sad and</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">Antagonistic scores</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">1.25 mg, p.o.</td>
                        <td align="left" rowspan="1" colspan="1">
                          <xref rid="pone.0028370-Abduljawad1" ref-type="bibr">[102]</xref>
                        </td>
                        <td align="left" rowspan="1" colspan="1">12</td>
                        <td align="left" rowspan="1" colspan="1">VAS</td>
                        <td align="left" rowspan="1" colspan="1">0</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">2.5 mg, p.o.</td>
                        <td align="left" rowspan="1" colspan="1">
                          <xref rid="pone.0028370-Muller1" ref-type="bibr">[103]</xref>
                        </td>
                        <td align="left" rowspan="1" colspan="1">16</td>
                        <td align="left" rowspan="1" colspan="1">AMS</td>
                        <td align="left" rowspan="1" colspan="1">0</td>
                        <td align="left" rowspan="1" colspan="1">Not clear what these scales measure</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">STAI</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">L-DOPA</td>
                        <td align="left" rowspan="1" colspan="1">Selective DA</td>
                        <td align="left" rowspan="1" colspan="1">100 mg, p.o.</td>
                        <td align="left" rowspan="1" colspan="1">
                          <xref rid="pone.0028370-Micallef1" ref-type="bibr">[97]</xref>
                        </td>
                        <td align="left" rowspan="1" colspan="1">12</td>
                        <td align="left" rowspan="1" colspan="1">VAS</td>
                        <td align="left" rowspan="1" colspan="1">0</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">augmenter</td>
                        <td align="left" rowspan="1" colspan="1">150 mg, p.o.</td>
                        <td align="left" rowspan="1" colspan="1">
                          <xref rid="pone.0028370-Evans3" ref-type="bibr">[88]</xref>
                        </td>
                        <td align="left" rowspan="1" colspan="1">14</td>
                        <td align="left" rowspan="1" colspan="1">VAS</td>
                        <td align="left" rowspan="1" colspan="1">0</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">200 mg, p.o.</td>
                        <td align="left" rowspan="1" colspan="1">
                          <xref rid="pone.0028370-Andreu1" ref-type="bibr">[104]</xref>
                        </td>
                        <td align="left" rowspan="1" colspan="1">22</td>
                        <td align="left" rowspan="1" colspan="1">VAS</td>
                        <td align="left" rowspan="1" colspan="1">NR</td>
                        <td align="left" rowspan="1" colspan="1">Only measured VAS “Drowsiness”</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Lisuride</td>
                        <td align="left" rowspan="1" colspan="1">D2 agonist</td>
                        <td align="left" rowspan="1" colspan="1">0.2 mg, p.o.</td>
                        <td align="left" rowspan="1" colspan="1">
                          <xref rid="pone.0028370-vanderPost1" ref-type="bibr">[105]</xref>
                        </td>
                        <td align="left" rowspan="1" colspan="1">12</td>
                        <td align="left" rowspan="1" colspan="1">VAS</td>
                        <td align="left" rowspan="1" colspan="1">↓</td>
                        <td align="left" rowspan="1" colspan="1">Adverse effects, such as nausea, vomiting and headache</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">No sedative effect</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Pergolide</td>
                        <td align="left" rowspan="1" colspan="1">Mixed D1/D2</td>
                        <td align="left" rowspan="1" colspan="1">0.1 mg, p.o.</td>
                        <td align="left" rowspan="1" colspan="1">
                          <xref rid="pone.0028370-Breitenstein1" ref-type="bibr">[106]</xref>
                        </td>
                        <td align="left" rowspan="1" colspan="1">40</td>
                        <td align="left" rowspan="1" colspan="1">PANAS</td>
                        <td align="left" rowspan="1" colspan="1">0</td>
                        <td align="left" rowspan="1" colspan="1">Drugs administered daily for 5 days</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">agonist</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">No acute drug effect (assessed on day 1)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">0.1 mg, p.o.</td>
                        <td align="left" rowspan="1" colspan="1">
                          <xref rid="pone.0028370-RoeschEly1" ref-type="bibr">[100]</xref>
                        </td>
                        <td align="left" rowspan="1" colspan="1">40</td>
                        <td align="left" rowspan="1" colspan="1">AMS</td>
                        <td align="left" rowspan="1" colspan="1">0</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">0.05 mg, p.o.</td>
                        <td align="left" rowspan="1" colspan="1">
                          <xref rid="pone.0028370-Upadhyaya1" ref-type="bibr">[107]</xref>
                        </td>
                        <td align="left" rowspan="1" colspan="1">15</td>
                        <td align="left" rowspan="1" colspan="1">VAS</td>
                        <td align="left" rowspan="1" colspan="1">0</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">0.1 mg, p.o.</td>
                        <td align="left" rowspan="1" colspan="1">
                          <xref rid="pone.0028370-Muller1" ref-type="bibr">[103]</xref>
                        </td>
                        <td align="left" rowspan="1" colspan="1">16</td>
                        <td align="left" rowspan="1" colspan="1">AMS</td>
                        <td align="left" rowspan="1" colspan="1">↓</td>
                        <td align="left" rowspan="1" colspan="1">Not clear what these scales measure</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">STAI</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Pramipexole</td>
                        <td align="left" rowspan="1" colspan="1">D2 agonist</td>
                        <td align="left" rowspan="1" colspan="1">0.5 mg, p.o.</td>
                        <td align="left" rowspan="1" colspan="1">
                          <xref rid="pone.0028370-Micallef1" ref-type="bibr">[97]</xref>
                        </td>
                        <td align="left" rowspan="1" colspan="1">12</td>
                        <td align="left" rowspan="1" colspan="1">VAS</td>
                        <td align="left" rowspan="1" colspan="1">0</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">0.25 mg, p.o.</td>
                        <td align="left" rowspan="1" colspan="1">
                          <xref rid="pone.0028370-Hamidovic2" ref-type="bibr">[108]</xref>
                        </td>
                        <td align="left" rowspan="1" colspan="1">10</td>
                        <td align="left" rowspan="1" colspan="1">POMS</td>
                        <td align="left" rowspan="1" colspan="1">↓</td>
                        <td align="left" rowspan="1" colspan="1">0.5 mg ↓ euphoria and energy as measured by ARCI, ↓ POMS</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">0.5 mg, p.o.</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">ARCI</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">vigor and positive mood and ↓ item “like drug” on DEQ</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">DEQ</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">0.5 mg, p.o.</td>
                        <td align="left" rowspan="1" colspan="1">
                          <xref rid="pone.0028370-Pizzagalli1" ref-type="bibr">[109]</xref>
                        </td>
                        <td align="left" rowspan="1" colspan="1">32</td>
                        <td align="left" rowspan="1" colspan="1">VAS</td>
                        <td align="left" rowspan="1" colspan="1">0</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Tolcapone</td>
                        <td align="left" rowspan="1" colspan="1">COMT</td>
                        <td align="left" rowspan="1" colspan="1">200 mg, p.o.</td>
                        <td align="left" rowspan="1" colspan="1">
                          <xref rid="pone.0028370-Roussos1" ref-type="bibr">[110]</xref>
                        </td>
                        <td align="left" rowspan="1" colspan="1">25</td>
                        <td align="left" rowspan="1" colspan="1">POMS</td>
                        <td align="left" rowspan="1" colspan="1">0</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">inhibitor</td>
                        <td align="left" rowspan="1" colspan="1">200 mg, p.o.</td>
                        <td align="left" rowspan="1" colspan="1">
                          <xref rid="pone.0028370-Giakoumaki1" ref-type="bibr">[111]</xref>
                        </td>
                        <td align="left" rowspan="1" colspan="1">23</td>
                        <td align="left" rowspan="1" colspan="1">POMS</td>
                        <td align="left" rowspan="1" colspan="1">0</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">100 mg p.o. day 1</td>
                        <td align="left" rowspan="1" colspan="1">
                          <xref rid="pone.0028370-Apud1" ref-type="bibr">[112]</xref>
                        </td>
                        <td align="left" rowspan="1" colspan="1">47</td>
                        <td align="left" rowspan="1" colspan="1">POMS</td>
                        <td align="left" rowspan="1" colspan="1">0</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">followed by 200</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">mg p.o. x 6 days</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                    </tbody>
                  </table>
                </alternatives>
                <table-wrap-foot>
                  <fn id="nt103">
                    <label/>
                    <p>For the purpose of this table, measures of positive mood include the ARCI MBG subscale, POMS “Elated” subscale, and the VAS items “High,” “Rush,” “Euphoria,” “Contentedness,” “Like Drug,” and “Good Effects.” Abbreviations: AMS, Adjective Mood Scale. ARCI, Addiction Research Center Inventory. NR, not reported. 0, No change. PANAS, Positive and Negative Affect Scales. POMS, Profile of Mood States. VAS, visual analog scales. STAI, State Trait Anxiety Inventory.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <p>The inability to detect effects of L-DOPA on positive mood does not preclude a relationship between DA neurotransmission, personality traits and goal-directed behavior <xref rid="pone.0028370-Murphy1" ref-type="bibr">[11]</xref>, <xref rid="pone.0028370-Leyton1" ref-type="bibr">[19]</xref>–<xref rid="pone.0028370-Buckholtz2" ref-type="bibr">[22]</xref>, <xref rid="pone.0028370-Leyton5" ref-type="bibr">[62]</xref>, <xref rid="pone.0028370-Willner1" ref-type="bibr">[63]</xref>; moreover, enhancements in goal-directed behavior may lead to elevated mood <xref rid="pone.0028370-Murphy1" ref-type="bibr">[11]</xref>, <xref rid="pone.0028370-Leyton5" ref-type="bibr">[62]</xref>–<xref rid="pone.0028370-Treadway1" ref-type="bibr">[64]</xref>. However, the present results suggest that drug-induced mood-elevating effects are more closely related to neurotransmitters other than DA <xref rid="pone.0028370-Ikemoto1" ref-type="bibr">[3]</xref>, <xref rid="pone.0028370-Salamone1" ref-type="bibr">[37]</xref>, <xref rid="pone.0028370-Leyton5" ref-type="bibr">[62]</xref>–<xref rid="pone.0028370-Wise4" ref-type="bibr">[69]</xref>, perhaps serotonin, norepinephrine, glutamate, GABA, endocannabinoids and endogenous opioids <xref rid="pone.0028370-Berridge1" ref-type="bibr">[2]</xref>, <xref rid="pone.0028370-Rothman1" ref-type="bibr">[70]</xref>–<xref rid="pone.0028370-Mahler1" ref-type="bibr">[75]</xref>.</p>
              <p>If DA's influence on reward seeking behaviors is not accounted for by enhanced pleasure, this raises the question of why it has these effects. Perhaps the best-supported alternative interpretation from the animal literature proposes that DA enhances the incentive salience of reward related cues, increasing their ability to elicit focused interest and sustain effortful seeking <xref rid="pone.0028370-Berridge1" ref-type="bibr">[2]</xref>, <xref rid="pone.0028370-Berridge3" ref-type="bibr">[43]</xref>, <xref rid="pone.0028370-Salamone3" ref-type="bibr">[76]</xref>. This conclusion is largely based on extensive evidence that decrements in DA neurotransmission reduce the willingness to work for rewards <xref rid="pone.0028370-Salamone1" ref-type="bibr">[37]</xref>, <xref rid="pone.0028370-Salamone3" ref-type="bibr">[76]</xref> without changing responses in an index of feeding related pleasure <xref rid="pone.0028370-Berridge1" ref-type="bibr">[2]</xref>, <xref rid="pone.0028370-Berridge3" ref-type="bibr">[43]</xref>. Accumulating work in humans supports this interpretation also (<xref rid="pone.0028370-Leyton5" ref-type="bibr">[62]</xref>, <xref ref-type="table" rid="pone-0028370-t002">Table 2</xref>). For example, in a series of studies conducted here, decreasing DA neurotransmission disrupted the tendency of subjects to respond preferentially to reward-related cues <xref rid="pone.0028370-Leyton2" ref-type="bibr">[55]</xref> and decreased the willingness to work for abused drugs <xref rid="pone.0028370-Barrett1" ref-type="bibr">[53]</xref>, <xref rid="pone.0028370-Venugopalan1" ref-type="bibr">[58]</xref> and monetary reward [Cawley et al, unpublished observations] on progressive ratio breakpoint schedules; each of these effects was produced without reductions in pleasure. Indeed, the majority of studies in humans have failed to replicate an ability of various DA lowering manipulations to diminish drug-induced pleasure <xref rid="pone.0028370-Brauer1" ref-type="bibr">[45]</xref>–<xref rid="pone.0028370-Venugopalan1" ref-type="bibr">[58]</xref>.</p>
              <p>The present results should be considered in light of the following. First, there was no direct measure of the ability of L-DOPA to increase DA, leaving open the possibility that mood changes were not detected because L-DOPA failed to increase DA levels. However, this seems unlikely since similar doses of L-DOPA given to healthy human volunteers induce behavioural effects <xref rid="pone.0028370-Eisenegger1" ref-type="bibr">[77]</xref>–<xref rid="pone.0028370-Pine1" ref-type="bibr">[79]</xref> and increase striatal DA synthesis <xref rid="pone.0028370-Kumakura1" ref-type="bibr">[80]</xref>. Pre-clinical studies confirm that L-DOPA increases DA levels in the intact brains of healthy animals, albeit to a lesser extent than in animal models of Parkinson's disease <xref rid="pone.0028370-Rodriguez1" ref-type="bibr">[81]</xref>. Although, to our knowledge, there are no reports of L-DOPA induced DA release in healthy humans, the administration of 250 mg more than doubles ventricular CSF levels of the DA metabolite, DOPAC <xref rid="pone.0028370-Raftopoulos1" ref-type="bibr">[82]</xref>. Moreover, robust L-DOPA induced DA responses have been seen in patients with Parkinson's disease <xref rid="pone.0028370-delaFuenteFernandez1" ref-type="bibr">[83]</xref>; intriguingly, these effects are largest in those who have developed pathological gambling and the “DA dysregulation syndrome” <xref rid="pone.0028370-Evans2" ref-type="bibr">[84]</xref>, <xref rid="pone.0028370-Steeves1" ref-type="bibr">[85]</xref>. Moreover, in these patients, larger L-DOPA-induced DA responses are associated with higher novelty- and fun-seeking personality traits, greater L-DOPA-induced psychomotor activation, and greater drug “wanting” but not drug “liking” <xref rid="pone.0028370-Evans2" ref-type="bibr">[84]</xref>. Testing the effect of larger increases in DA neurotransmission in healthy human volunteers will be difficult, though, since higher doses of all currently available drugs that selectively augment DA neurotransmission are limited by side effects such as nausea, vomiting, dizziness and drowsiness. Indeed, this limitation guided our selection of L-DOPA doses in the present study. Second, we used a median split to determine the high and low sub-groups for each of the approach-related personality traits. It might be necessary to recruit participants from the more extreme ends of the normative population distribution for each of these traits in order to detect a differential effect of a DAergic drug, since individual differences in DA neurotransmission might be more pronounced in these more extreme ends of the distribution. This noted, a <italic>post hoc</italic> examination of our more extreme upper and lower quartiles also failed to identify an effect on mood (all p-values≥0.15). Finally, it is possible that an effect on mood would have been seen with a larger sample size. However, this is considered unlikely. The single largest effect size was peak change to ‘Energetic-Tired’ scores (d = 0.339), and this would have required a sample of 138. All other effects would require samples larger than 200. Following corrections for multiple comparisons, these numbers increase further again.</p>
              <p>In conclusion, L-DOPA failed to produce changes in positive mood states in a group of healthy human volunteers. These findings add to an accumulating literature suggesting that increases in DA neurotransmission are not sufficient to directly generate positive emotions.</p>
            </sec>
            <sec sec-type="methods" id="s4">
              <title>Methods</title>
              <sec id="s4a">
                <title>Ethics Statement</title>
                <p>The study was carried out in accordance with the Declaration of Helsinki and was approved by the Research Ethics Board of the McGill University Hospital Centre. All subjects gave informed written consent.</p>
              </sec>
              <sec id="s4b">
                <title>Subjects</title>
                <p>Fifty participants were recruited from the McGill University campus through online classified advertisements. Forty-eight men and women (29 females and 19 males; mean age 21.9±3.7 years) completed the study. One participant was excluded due to vomiting at the beginning of the test session and another was excluded because of failure to comprehend the task instructions. All were healthy, as determined by a physical exam, standard laboratory tests, and an interview with the Structured Clinical Interview for DSM-IV, axis I <xref rid="pone.0028370-First1" ref-type="bibr">[86]</xref>. None had a personal history of axis I psychiatric disorders. On the test day, all subjects tested negative on a urine drug screen sensitive to cocaine, opiates, phencyclidine, barbiturates, Δ<sup>9</sup>-tetrahydrocannabinol, and amphetamines (Triage Panel for Drugs of Abuse, Biosite Diagnostics©, San Diego, CA).</p>
              </sec>
              <sec id="s4c">
                <title>Procedure</title>
                <p>Participants completed the personality questionnaires on the same day as the psychiatric interview, while the test session took place on a separate day. Participants also completed a battery of cognitive tasks during the test session, but these results will be reported elsewhere. Participants were assigned to one of three drug groups (n = 16 per group): placebo, L-DOPA/carbidopa (Sinemet, 100mg/25 mg) or L-DOPA/carbidopa (Sinemet, 200 mg/50 mg), in a randomized, double blind, between-groups design. A combination drug, including the peripheral decarboxylase inhibitor carbidopa, was used to prevent the conversion of L-DOPA to DA before it entered the brain. Low doses of L-DOPA were administered in an effort to avoid the potential confound of side effects such as nausea, vomiting and dizziness. On the test day, participants arrived in the laboratory at 11:30 AM and completed baseline subjective state questionnaires and drug screening. At 12:30 PM, participants ingested two green capsules containing either placebo or one of the two doses of L-DOPA. Participants completed the mood questionnaires at three additional times: 45 minutes, 105 minutes and 165 minutes post-capsule ingestion. Cognitive testing commenced 45 minutes following ingestion of the capsules, coinciding with the time to peak blood concentration of L-DOPA and lasted until 3:30 PM. Female participants who were not taking oral contraceptives were tested within 10 days of the start of menstruation because previous studies have shown that females are more sensitive to reward in the follicular compared to the luteal phase of the menstrual cycle <xref rid="pone.0028370-Dreher1" ref-type="bibr">[87]</xref>–<xref rid="pone.0028370-Sofuoglu1" ref-type="bibr">[89]</xref>.</p>
              </sec>
              <sec id="s4d">
                <title>Personality Measures</title>
                <p>All subjects completed the Tridimensional Personality Questionnaire (TPQ) <xref rid="pone.0028370-Cloninger1" ref-type="bibr">[90]</xref>, Substance Use Risk Profile (SURPS) <xref rid="pone.0028370-Woicik1" ref-type="bibr">[91]</xref> and the Neuroticism-Extroversion-Openness Five Factor Inventory (NEO-FFI) <xref rid="pone.0028370-Costa1" ref-type="bibr">[92]</xref>. Of specific interest in the present study were the TPQ Novelty Seeking factor and two of its subscales (NS1, Exploratory-Excitability and NS2, Impulsiveness), the SURPS factors Impulsivity and Sensation Seeking, and the NEO-FFI factor Extraversion. Each drug group was further sub-divided into high and low groups based on a median split of these personality factor scores for each subject.</p>
              </sec>
              <sec id="s4e">
                <title>Mood and Subjective Effects Measures</title>
                <p>Subjective effects were measured with the bipolar Profile of Mood States (POMS), a sensitive measure of small rapid changes in mood <xref rid="pone.0028370-Lorr1" ref-type="bibr">[93]</xref>, <xref rid="pone.0028370-Lorr2" ref-type="bibr">[94]</xref>, and a visual analog scale (VAS) labeled “Nauseous”. The POMS is comprised of 72 adjectives that describe various mood states. Participants indicate the extent to which they feel these states at each time point on a scale ranging from 0 (“not at all”) to 4 (“extremely”). The POMS items are then converted into 6 empirically derived sub-scales: Elated-Depressed, Composed-Anxious, Agreeable-Hostile, Confident-Unsure, Energetic-Tired and Clearheaded-Confused. Both questionnaires were administered at four times on the test day: at baseline, and at 45, 105 and 165 minutes post-capsule ingestion.</p>
              </sec>
              <sec id="s4f">
                <title>Data Analyses</title>
                <p>Data analyses were conducted using SPSS Statistics (version 18.0; IBM, Chicago, Illinois). Each drug group was further subdivided based on a median split of scores for the approach-related personality traits of Impulsivity, Extraversion, Sensation Seeking and Novelty Seeking, yielding high and low groups for each factor. Three separate analyses were conducted for TPQ Novelty Seeking: the total score as well as scores for the Exploratory-Excitability (NS1) and Impulsiveness (NS2) subscales. Three-way mixed design ANOVAs were used to assess the effects of drug group (independent factor, 3 levels: placebo, 100 mg L-DOPA, 200 mg L-DOPA) and personality trait sub-group (independent factor, 2 levels: high and low) across time (repeated factor, 4 levels: baseline, +45 minutes, +105 minutes and +165 minutes) for all of the mood and subjective effects measures. Two-way independent groups ANOVAs were used to assess the effects of drug group and personality trait subgroup on POMS absolute peak change scores, calculated as the largest difference between any of the three time points and baseline. Post-hoc Least Significant Differences (LSD) tests were used whenever an ANOVA yielded a significant result. The significance for all statistical tests was p&lt;0.05.</p>
              </sec>
            </sec>
          </body>
          <back>
            <fn-group>
              <fn fn-type="COI-statement">
                <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
              </fn>
              <fn fn-type="financial-disclosure">
                <p><bold>Funding: </bold>This work was funded by an operating grant from the Canadian Institutes of Health Research (MOP-36429) &lt;<ext-link ext-link-type="uri" xlink:href="http://www.cihr-irsc.gc.ca/e/193.html">www.cihr-irsc.gc.ca/e/193.html</ext-link>&gt; and William Dawson fund from McGill University &lt;<ext-link ext-link-type="uri" xlink:href="http://www.mcgill.ca/ap-facultyaffairs/mcgilldawson">www.mcgill.ca/ap-facultyaffairs/mcgilldawson</ext-link>&gt;, both to ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p>
              </fn>
            </fn-group>
            <ref-list>
              <title>References</title>
              <ref id="pone.0028370-Wise1">
                <label>1</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wise</surname>
                      <given-names>RA</given-names>
                    </name>
                    <name>
                      <surname>Rompre</surname>
                      <given-names>PP</given-names>
                    </name>
                  </person-group>
                  <year>1989</year>
                  <article-title>Brain dopamine and reward.</article-title>
                  <source>Annu Rev Psychol</source>
                  <volume>40</volume>
                  <fpage>191</fpage>
                  <lpage>225</lpage>
                  <pub-id pub-id-type="pmid">2648975</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Berridge1">
                <label>2</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Berridge</surname>
                      <given-names>KC</given-names>
                    </name>
                    <name>
                      <surname>Robinson</surname>
                      <given-names>TE</given-names>
                    </name>
                  </person-group>
                  <year>1998</year>
                  <article-title>What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive salience?</article-title>
                  <source>Brain Res Rev</source>
                  <volume>28</volume>
                  <fpage>309</fpage>
                  <lpage>369</lpage>
                  <pub-id pub-id-type="pmid">9858756</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Ikemoto1">
                <label>3</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ikemoto</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Panksepp</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <year>1999</year>
                  <article-title>The role of nucleus accumbens dopamine in motivated behavior: A unifying interpretation with special reference to reward-seeking.</article-title>
                  <source>Brain Res Rev</source>
                  <volume>31</volume>
                  <fpage>6</fpage>
                  <lpage>41</lpage>
                  <pub-id pub-id-type="pmid">10611493</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Phillips1">
                <label>4</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Phillips</surname>
                      <given-names>AG</given-names>
                    </name>
                    <name>
                      <surname>Pfaus</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Blaha</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <year>1991</year>
                  <article-title>Dopamine and motivated behavior: Insights provided by in vivo analyses.</article-title>
                  <person-group person-group-type="editor">
                    <name>
                      <surname>Willner</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Scheel-Kruger</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <source>The Mesolimbic Dopamine System: From Motivation to Action</source>
                  <publisher-loc>Chichester, UK</publisher-loc>
                  <publisher-name>John Wiley &amp; Sons Ltd</publisher-name>
                  <fpage>199</fpage>
                  <lpage>224</lpage>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Stewart1">
                <label>5</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Stewart</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>de Wit</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Eikelboom</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <year>1984</year>
                  <article-title>Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants.</article-title>
                  <source>Psychol Rev</source>
                  <volume>91</volume>
                  <fpage>251</fpage>
                  <lpage>268</lpage>
                  <pub-id pub-id-type="pmid">6571424</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Wise2">
                <label>6</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wise</surname>
                      <given-names>RA</given-names>
                    </name>
                  </person-group>
                  <year>1982</year>
                  <article-title>Neuroleptics and operant-behavior - the anhedonia hypothesis.</article-title>
                  <source>Behav Brain Sci</source>
                  <volume>5</volume>
                  <fpage>39</fpage>
                  <lpage>53</lpage>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Gunne1">
                <label>7</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gunne</surname>
                      <given-names>LM</given-names>
                    </name>
                    <name>
                      <surname>Anggard</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Jonsson</surname>
                      <given-names>LE</given-names>
                    </name>
                  </person-group>
                  <year>1972</year>
                  <article-title>Clinical trials with amphetamine-blocking drugs.</article-title>
                  <source>Psychiatr Neurol Neurochir</source>
                  <volume>75</volume>
                  <fpage>225</fpage>
                  <lpage>226</lpage>
                  <pub-id pub-id-type="pmid">4402653</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Jonsson1">
                <label>8</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jonsson</surname>
                      <given-names>LE</given-names>
                    </name>
                  </person-group>
                  <year>1972</year>
                  <article-title>Pharmacological blockade of amphetamine effects in amphetamine dependent subjects.</article-title>
                  <source>Eur J Clin Pharmacol</source>
                  <volume>4</volume>
                  <fpage>206</fpage>
                  <lpage>211</lpage>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Jonsson2">
                <label>9</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jonsson</surname>
                      <given-names>LE</given-names>
                    </name>
                    <name>
                      <surname>Anggard</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Gunne</surname>
                      <given-names>LM</given-names>
                    </name>
                  </person-group>
                  <year>1971</year>
                  <article-title>Blockade of intravenous amphetamine euphoria in man.</article-title>
                  <source>Clin Pharmacol Ther</source>
                  <volume>12</volume>
                  <fpage>889</fpage>
                  <lpage>896</lpage>
                  <pub-id pub-id-type="pmid">4944167</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Singh1">
                <label>10</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Singh</surname>
                      <given-names>MM</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>JM</given-names>
                    </name>
                  </person-group>
                  <year>1973</year>
                  <article-title>Kinetics and dynamics of response to haloperidol in acute schizophrenia–A longitudinal study of the therapeutic process.</article-title>
                  <source>Compr Psychiatry</source>
                  <volume>14</volume>
                  <fpage>393</fpage>
                  <lpage>414</lpage>
                  <pub-id pub-id-type="pmid">4741976</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Murphy1">
                <label>11</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Murphy</surname>
                      <given-names>DL</given-names>
                    </name>
                    <name>
                      <surname>Brodie</surname>
                      <given-names>HKH</given-names>
                    </name>
                    <name>
                      <surname>Goodwin</surname>
                      <given-names>FK</given-names>
                    </name>
                    <name>
                      <surname>Bunney</surname>
                      <given-names>WE</given-names>
                      <suffix>Jr</suffix>
                    </name>
                  </person-group>
                  <year>1971</year>
                  <article-title>Regular induction of hypomania by L-DOPA in “bipolar” manic-depressive disorder patients.</article-title>
                  <source>Nature</source>
                  <volume>229</volume>
                  <fpage>135</fpage>
                  <lpage>136</lpage>
                  <pub-id pub-id-type="pmid">4321339</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Phillips2">
                <label>12</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Phillips</surname>
                      <given-names>AG</given-names>
                    </name>
                    <name>
                      <surname>Fibiger</surname>
                      <given-names>HC</given-names>
                    </name>
                  </person-group>
                  <year>1973</year>
                  <article-title>Dopaminergic and noradrenergic substrates of positive reinforcement: differential effects of d- and l-amphetamine.</article-title>
                  <source>Science</source>
                  <volume>179</volume>
                  <fpage>575</fpage>
                  <lpage>577</lpage>
                  <pub-id pub-id-type="pmid">4686463</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Fouriezos1">
                <label>13</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fouriezos</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Hansson</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Wise</surname>
                      <given-names>RA</given-names>
                    </name>
                  </person-group>
                  <year>1978</year>
                  <article-title>Neuroleptic-induced attenuation of brain stimulation reward in rats.</article-title>
                  <source>J Comp Physiol Psychol</source>
                  <volume>92</volume>
                  <fpage>661</fpage>
                  <lpage>671</lpage>
                  <pub-id pub-id-type="pmid">29060</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Fouriezos2">
                <label>14</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fouriezos</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Wise</surname>
                      <given-names>RA</given-names>
                    </name>
                  </person-group>
                  <year>1976</year>
                  <article-title>Pimozide-induced extinction of intracranial self-stimulation: response patterns rule out motor or performance deficits.</article-title>
                  <source>Brain Res</source>
                  <volume>103</volume>
                  <fpage>377</fpage>
                  <lpage>380</lpage>
                  <pub-id pub-id-type="pmid">1252926</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Franklin1">
                <label>15</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Franklin</surname>
                      <given-names>KB</given-names>
                    </name>
                    <name>
                      <surname>McCoy</surname>
                      <given-names>SN</given-names>
                    </name>
                  </person-group>
                  <year>1979</year>
                  <article-title>Pimozide-induced extinction in rats: stimulus control of responding rules out motor deficit.</article-title>
                  <source>Pharmacol Biochem Behav</source>
                  <volume>11</volume>
                  <fpage>71</fpage>
                  <lpage>75</lpage>
                  <pub-id pub-id-type="pmid">493299</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Wise3">
                <label>16</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wise</surname>
                      <given-names>RA</given-names>
                    </name>
                  </person-group>
                  <year>1978</year>
                  <article-title>Catecholamine theories of reward: A critical review.</article-title>
                  <source>Brain Res</source>
                  <volume>152</volume>
                  <fpage>215</fpage>
                  <lpage>247</lpage>
                  <pub-id pub-id-type="pmid">354753</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Yokel1">
                <label>17</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yokel</surname>
                      <given-names>RA</given-names>
                    </name>
                    <name>
                      <surname>Wise</surname>
                      <given-names>RA</given-names>
                    </name>
                  </person-group>
                  <year>1975</year>
                  <article-title>Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward.</article-title>
                  <source>Science</source>
                  <volume>187</volume>
                  <fpage>547</fpage>
                  <lpage>549</lpage>
                  <pub-id pub-id-type="pmid">1114313</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Yokel2">
                <label>18</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yokel</surname>
                      <given-names>RA</given-names>
                    </name>
                    <name>
                      <surname>Wise</surname>
                      <given-names>RA</given-names>
                    </name>
                  </person-group>
                  <year>1976</year>
                  <article-title>Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats.</article-title>
                  <source>Psychopharmacology (Berl)</source>
                  <volume>48</volume>
                  <fpage>311</fpage>
                  <lpage>318</lpage>
                  <pub-id pub-id-type="pmid">823588</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Leyton1">
                <label>19</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Leyton</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Boileau</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Benkelfat</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Diksic</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Baker</surname>
                      <given-names>G</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2002</year>
                  <article-title>Amphetamine-induced increases in extracellular dopamine, drug wanting and novelty seeking: A PET [<sup>11</sup>C]raclopride study in healthy men.</article-title>
                  <source>Neuropsychopharmacology</source>
                  <volume>27</volume>
                  <fpage>1027</fpage>
                  <lpage>1035</lpage>
                  <pub-id pub-id-type="pmid">12464459</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Boileau1">
                <label>20</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Boileau</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Assaad</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Pihl</surname>
                      <given-names>RO</given-names>
                    </name>
                    <name>
                      <surname>Benkelfat</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Leyton</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2003</year>
                  <article-title>Alcohol promotes dopamine release in the human nucleus accumbens.</article-title>
                  <source>Synapse</source>
                  <volume>49</volume>
                  <fpage>226</fpage>
                  <lpage>231</lpage>
                  <pub-id pub-id-type="pmid">12827641</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Buckholtz1">
                <label>21</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Buckholtz</surname>
                      <given-names>JW</given-names>
                    </name>
                    <name>
                      <surname>Treadway</surname>
                      <given-names>MT</given-names>
                    </name>
                    <name>
                      <surname>Cowan</surname>
                      <given-names>RL</given-names>
                    </name>
                    <name>
                      <surname>Woodward</surname>
                      <given-names>ND</given-names>
                    </name>
                    <name>
                      <surname>Benning</surname>
                      <given-names>SD</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2010</year>
                  <article-title>Mesolimbic dopamine reward system hypersensitivity in individuals with psychopathic traits.</article-title>
                  <source>Nat Neurosci</source>
                  <volume>13</volume>
                  <fpage>419</fpage>
                  <lpage>421</lpage>
                  <pub-id pub-id-type="pmid">20228805</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Buckholtz2">
                <label>22</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Buckholtz</surname>
                      <given-names>JW</given-names>
                    </name>
                    <name>
                      <surname>Treadway</surname>
                      <given-names>MT</given-names>
                    </name>
                    <name>
                      <surname>Cowan</surname>
                      <given-names>RL</given-names>
                    </name>
                    <name>
                      <surname>Woodward</surname>
                      <given-names>ND</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>R</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2010</year>
                  <article-title>Dopaminergic network differences in human impulsivity.</article-title>
                  <source>Science</source>
                  <volume>329</volume>
                  <fpage>532</fpage>
                  <pub-id pub-id-type="pmid">20671181</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Oswald1">
                <label>23</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Oswald</surname>
                      <given-names>LM</given-names>
                    </name>
                    <name>
                      <surname>Wong</surname>
                      <given-names>DF</given-names>
                    </name>
                    <name>
                      <surname>McCaul</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Zhou</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Kuwabara</surname>
                      <given-names>H</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2005</year>
                  <article-title>Relationships among ventral striatal dopamine release, cortisol secretion, and subjective responses to amphetamine.</article-title>
                  <source>Neuropsychopharmacology</source>
                  <volume>30</volume>
                  <fpage>821</fpage>
                  <lpage>832</lpage>
                  <pub-id pub-id-type="pmid">15702139</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Oswald2">
                <label>24</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Oswald</surname>
                      <given-names>LM</given-names>
                    </name>
                    <name>
                      <surname>Wong</surname>
                      <given-names>DF</given-names>
                    </name>
                    <name>
                      <surname>Zhou</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Kumar</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Brasic</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2007</year>
                  <article-title>Impulsivity and chronic stress are associated with amphetamine-induced striatal dopamine release.</article-title>
                  <source>NeuroImage</source>
                  <volume>36</volume>
                  <fpage>153</fpage>
                  <lpage>166</lpage>
                  <pub-id pub-id-type="pmid">17433881</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-AbiDargham1">
                <label>25</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Abi-Dargham</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Kegeles</surname>
                      <given-names>LS</given-names>
                    </name>
                    <name>
                      <surname>Martinez</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Innis</surname>
                      <given-names>RB</given-names>
                    </name>
                    <name>
                      <surname>Laruelle</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <year>2003</year>
                  <article-title>Dopamine mediation of positive reinforcing effects of amphetamine in stimulant naive healthy volunteers: Results from a large cohort.</article-title>
                  <source>Eur Neuropsychopharmacol</source>
                  <volume>13</volume>
                  <fpage>459</fpage>
                  <lpage>468</lpage>
                  <pub-id pub-id-type="pmid">14636962</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Boileau2">
                <label>26</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Boileau</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Dagher</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Leyton</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Welfeld</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Booij</surname>
                      <given-names>L</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2007</year>
                  <article-title>Conditioned dopamine release in humans: A positron emission tomography [<sup>11</sup>C]raclopride study with amphetamine.</article-title>
                  <source>J Neurosci</source>
                  <volume>27</volume>
                  <fpage>3998</fpage>
                  <lpage>4003</lpage>
                  <pub-id pub-id-type="pmid">17428975</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Drevets1">
                <label>27</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Drevets</surname>
                      <given-names>WC</given-names>
                    </name>
                    <name>
                      <surname>Gautier</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Price</surname>
                      <given-names>JC</given-names>
                    </name>
                    <name>
                      <surname>Kupfer</surname>
                      <given-names>DJ</given-names>
                    </name>
                    <name>
                      <surname>Kinahan</surname>
                      <given-names>PE</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2001</year>
                  <article-title>Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria.</article-title>
                  <source>Biol Psychiatry</source>
                  <volume>49</volume>
                  <fpage>81</fpage>
                  <lpage>96</lpage>
                  <pub-id pub-id-type="pmid">11164755</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Laruelle1">
                <label>28</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Laruelle</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Abi-Dargham</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>van Dyck</surname>
                      <given-names>CH</given-names>
                    </name>
                    <name>
                      <surname>Rosenblatt</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Zea-Ponce</surname>
                      <given-names>Y</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>1995</year>
                  <article-title>SPECT imaging of striatal dopamine release after amphetamine challenge.</article-title>
                  <source>J Nucl Med</source>
                  <volume>36</volume>
                  <fpage>1182</fpage>
                  <lpage>1190</lpage>
                  <pub-id pub-id-type="pmid">7790942</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Martinez1">
                <label>29</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Martinez</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Slifstein</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Broft</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Mawlawi</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>Hwang</surname>
                      <given-names>DR</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2003</year>
                  <article-title>Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum.</article-title>
                  <source>J Cereb Blood Flow Metab</source>
                  <volume>23</volume>
                  <fpage>285</fpage>
                  <lpage>300</lpage>
                  <pub-id pub-id-type="pmid">12621304</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Munro1">
                <label>30</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Munro</surname>
                      <given-names>CA</given-names>
                    </name>
                    <name>
                      <surname>McCaul</surname>
                      <given-names>ME</given-names>
                    </name>
                    <name>
                      <surname>Wong</surname>
                      <given-names>DF</given-names>
                    </name>
                    <name>
                      <surname>Oswald</surname>
                      <given-names>LM</given-names>
                    </name>
                    <name>
                      <surname>Zhou</surname>
                      <given-names>Y</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2006</year>
                  <article-title>Sex differences in striatal dopamine release in healthy adults.</article-title>
                  <source>Biol Psychiatry</source>
                  <volume>59</volume>
                  <fpage>966</fpage>
                  <lpage>974</lpage>
                  <pub-id pub-id-type="pmid">16616726</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Volkow1">
                <label>31</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Volkow</surname>
                      <given-names>ND</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>GJ</given-names>
                    </name>
                    <name>
                      <surname>Fowler</surname>
                      <given-names>JS</given-names>
                    </name>
                    <name>
                      <surname>Logan</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Gatley</surname>
                      <given-names>SJ</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>1999</year>
                  <article-title>Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors.</article-title>
                  <source>J Pharmacol Exp Ther</source>
                  <volume>291</volume>
                  <fpage>409</fpage>
                  <lpage>415</lpage>
                  <pub-id pub-id-type="pmid">10490931</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Bressan1">
                <label>32</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bressan</surname>
                      <given-names>RA</given-names>
                    </name>
                    <name>
                      <surname>Costa</surname>
                      <given-names>DC</given-names>
                    </name>
                    <name>
                      <surname>Jones</surname>
                      <given-names>HM</given-names>
                    </name>
                    <name>
                      <surname>Ell</surname>
                      <given-names>PJ</given-names>
                    </name>
                    <name>
                      <surname>Pilowsky</surname>
                      <given-names>LS</given-names>
                    </name>
                  </person-group>
                  <year>2002</year>
                  <article-title>Typical antipsychotic drugs – D(2) receptor occupancy and depressive symptoms in schizophrenia.</article-title>
                  <source>Schizophr Res</source>
                  <volume>56</volume>
                  <fpage>31</fpage>
                  <lpage>36</lpage>
                  <pub-id pub-id-type="pmid">12084417</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-deHaan1">
                <label>33</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>de Haan</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Lavalaye</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Linszen</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Dingemans</surname>
                      <given-names>PMAJ</given-names>
                    </name>
                    <name>
                      <surname>Booij</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <year>2000</year>
                  <article-title>Subjective experience and striatal dopamine D-2 receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone.</article-title>
                  <source>Am J Psychiatry</source>
                  <volume>157</volume>
                  <fpage>1019</fpage>
                  <lpage>1020</lpage>
                  <pub-id pub-id-type="pmid">10831489</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Mizrahi1">
                <label>34</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mizrahi</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Rusjan</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Agid</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>Graff</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Mamo</surname>
                      <given-names>DC</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2007</year>
                  <article-title>Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D-2 receptors: A PET study in schizophrenia.</article-title>
                  <source>Am J Psychiatry</source>
                  <volume>164</volume>
                  <fpage>630</fpage>
                  <lpage>637</lpage>
                  <pub-id pub-id-type="pmid">17403977</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Pruessner1">
                <label>35</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pruessner</surname>
                      <given-names>JC</given-names>
                    </name>
                    <name>
                      <surname>Champagne</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Meaney</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <name>
                      <surname>Dagher</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <year>2004</year>
                  <article-title>Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: A positron emission tomography study using [<sup>11</sup>C]raclopride.</article-title>
                  <source>J Neurosci</source>
                  <volume>24</volume>
                  <fpage>2825</fpage>
                  <lpage>2831</lpage>
                  <pub-id pub-id-type="pmid">15028776</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Scott1">
                <label>36</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Scott</surname>
                      <given-names>DJ</given-names>
                    </name>
                    <name>
                      <surname>Heitzeg</surname>
                      <given-names>MM</given-names>
                    </name>
                    <name>
                      <surname>Koeppe</surname>
                      <given-names>RA</given-names>
                    </name>
                    <name>
                      <surname>Stohler</surname>
                      <given-names>CS</given-names>
                    </name>
                    <name>
                      <surname>Zubieta</surname>
                      <given-names>JK</given-names>
                    </name>
                  </person-group>
                  <year>2006</year>
                  <article-title>Variations in the human pain stress experience mediated by ventral and dorsal basal ganglia dopamine activity.</article-title>
                  <source>J Neurosci</source>
                  <volume>26</volume>
                  <fpage>10789</fpage>
                  <lpage>10795</lpage>
                  <pub-id pub-id-type="pmid">17050717</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Salamone1">
                <label>37</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Salamone</surname>
                      <given-names>JD</given-names>
                    </name>
                  </person-group>
                  <year>1994</year>
                  <article-title>The involvement of nucleus accumbens dopamine in appetitive and aversive motivation.</article-title>
                  <source>Behav Brain Res</source>
                  <volume>61</volume>
                  <fpage>117</fpage>
                  <lpage>133</lpage>
                  <pub-id pub-id-type="pmid">8037860</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Gratton1">
                <label>38</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gratton</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Wise</surname>
                      <given-names>RA</given-names>
                    </name>
                  </person-group>
                  <year>1994</year>
                  <article-title>Drug- and behavior-associated changes in dopamine-related electrochemical signals during intravenous cocaine self-administration in rats.</article-title>
                  <source>J Neurosci</source>
                  <volume>14</volume>
                  <fpage>4130</fpage>
                  <lpage>4146</lpage>
                  <pub-id pub-id-type="pmid">8027767</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Kiyatkin1">
                <label>39</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kiyatkin</surname>
                      <given-names>EA</given-names>
                    </name>
                    <name>
                      <surname>Gratton</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <year>1994</year>
                  <article-title>Electrochemical monitoring of extracellular dopamine in nucleus accumbens of rats lever-pressing for food.</article-title>
                  <source>Brain Res</source>
                  <volume>652</volume>
                  <fpage>225</fpage>
                  <lpage>234</lpage>
                  <pub-id pub-id-type="pmid">7953734</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Schultz1">
                <label>40</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Schultz</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Romo</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <year>1990</year>
                  <article-title>Dopamine neurons of the monkey midbrain: Contingencies of responses to stimuli eliciting immediate behavioral reactions.</article-title>
                  <source>J Neurophysiol</source>
                  <volume>63</volume>
                  <fpage>607</fpage>
                  <lpage>624</lpage>
                  <pub-id pub-id-type="pmid">2329364</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Gratton2">
                <label>41</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gratton</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <year>1996</year>
                  <article-title>In vivo analysis of the role of dopamine in stimulant and opiate self-administration.</article-title>
                  <source>J Psychiatry Neurosci</source>
                  <volume>21</volume>
                  <fpage>264</fpage>
                  <lpage>279</lpage>
                  <pub-id pub-id-type="pmid">8754596</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Berridge2">
                <label>42</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Berridge</surname>
                      <given-names>KC</given-names>
                    </name>
                    <name>
                      <surname>Venier</surname>
                      <given-names>IL</given-names>
                    </name>
                    <name>
                      <surname>Robinson</surname>
                      <given-names>TE</given-names>
                    </name>
                  </person-group>
                  <year>1989</year>
                  <article-title>Taste reactivity analysis of 6-hydroxydopamine-induced aphagia: Implications for arousal and anhedonia hypotheses of dopamine function.</article-title>
                  <source>Behav Neurosci</source>
                  <volume>103</volume>
                  <fpage>36</fpage>
                  <lpage>45</lpage>
                  <pub-id pub-id-type="pmid">2493791</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Berridge3">
                <label>43</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Berridge</surname>
                      <given-names>KC</given-names>
                    </name>
                  </person-group>
                  <year>2007</year>
                  <article-title>The debate over dopamine's role in reward: The case for incentive salience.</article-title>
                  <source>Psychopharmacology</source>
                  <volume>191</volume>
                  <fpage>391</fpage>
                  <lpage>431</lpage>
                  <pub-id pub-id-type="pmid">17072591</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Romach1">
                <label>44</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Romach</surname>
                      <given-names>MK</given-names>
                    </name>
                    <name>
                      <surname>Glue</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Kampman</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Kaplan</surname>
                      <given-names>HL</given-names>
                    </name>
                    <name>
                      <surname>Somer</surname>
                      <given-names>GR</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>1999</year>
                  <article-title>Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166).</article-title>
                  <source>Arch Gen Psychiatry</source>
                  <volume>56</volume>
                  <fpage>1101</fpage>
                  <lpage>1106</lpage>
                  <pub-id pub-id-type="pmid">10591286</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Brauer1">
                <label>45</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Brauer</surname>
                      <given-names>LH</given-names>
                    </name>
                    <name>
                      <surname>de Wit</surname>
                      <given-names>H</given-names>
                    </name>
                  </person-group>
                  <year>1996</year>
                  <article-title>Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers.</article-title>
                  <source>Biol Psychiatry</source>
                  <volume>39</volume>
                  <fpage>26</fpage>
                  <lpage>32</lpage>
                  <pub-id pub-id-type="pmid">8719123</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Brauer2">
                <label>46</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Brauer</surname>
                      <given-names>LH</given-names>
                    </name>
                    <name>
                      <surname>de Wit</surname>
                      <given-names>H</given-names>
                    </name>
                  </person-group>
                  <year>1997</year>
                  <article-title>High dose pimozide does not block amphetamine-induced euphoria in normal volunteers.</article-title>
                  <source>Pharmacol Biochem Behav</source>
                  <volume>56</volume>
                  <fpage>265</fpage>
                  <lpage>272</lpage>
                  <pub-id pub-id-type="pmid">9050084</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Brauer3">
                <label>47</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Brauer</surname>
                      <given-names>LH</given-names>
                    </name>
                    <name>
                      <surname>de Wit</surname>
                      <given-names>H</given-names>
                    </name>
                  </person-group>
                  <year>1995</year>
                  <article-title>Role of dopamine in d-amphetamine-induced euphoria in normal, healthy volunteers.</article-title>
                  <source>Exp Clin Psychopharmacol</source>
                  <volume>3</volume>
                  <fpage>371</fpage>
                  <lpage>381</lpage>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Evans1">
                <label>48</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Evans</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Walsh</surname>
                      <given-names>SL</given-names>
                    </name>
                    <name>
                      <surname>Levin</surname>
                      <given-names>FR</given-names>
                    </name>
                    <name>
                      <surname>Foltin</surname>
                      <given-names>RW</given-names>
                    </name>
                    <name>
                      <surname>Fischman</surname>
                      <given-names>MW</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2001</year>
                  <article-title>Effect of flupenthixol on subjective and cardiovascular responses to intravenous cocaine in humans.</article-title>
                  <source>Drug Alcohol Depend</source>
                  <volume>64</volume>
                  <fpage>271</fpage>
                  <lpage>283</lpage>
                  <pub-id pub-id-type="pmid">11672942</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Gawin1">
                <label>49</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gawin</surname>
                      <given-names>FH</given-names>
                    </name>
                  </person-group>
                  <year>1986</year>
                  <article-title>Neuroleptic reduction of cocaine-induced paranoia but not euphoria?</article-title>
                  <source>Psychopharmacology (Berl)</source>
                  <volume>90</volume>
                  <fpage>142</fpage>
                  <lpage>143</lpage>
                  <pub-id pub-id-type="pmid">2876452</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Haney1">
                <label>50</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Haney</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Ward</surname>
                      <given-names>AS</given-names>
                    </name>
                    <name>
                      <surname>Foltin</surname>
                      <given-names>RW</given-names>
                    </name>
                    <name>
                      <surname>Fischman</surname>
                      <given-names>MW</given-names>
                    </name>
                  </person-group>
                  <year>2001</year>
                  <article-title>Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans.</article-title>
                  <source>Psychopharmacology (Berl)</source>
                  <volume>155</volume>
                  <fpage>330</fpage>
                  <lpage>337</lpage>
                  <pub-id pub-id-type="pmid">11441422</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-NannVernotica1">
                <label>51</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nann-Vernotica</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Donny</surname>
                      <given-names>EC</given-names>
                    </name>
                    <name>
                      <surname>Bigelow</surname>
                      <given-names>GE</given-names>
                    </name>
                    <name>
                      <surname>Walsh</surname>
                      <given-names>SL</given-names>
                    </name>
                  </person-group>
                  <year>2001</year>
                  <article-title>Repeated administration of the D1/5 antagonist ecopipam fails to attenuate the subjective effects of cocaine.</article-title>
                  <source>Psychopharmacology (Berl)</source>
                  <volume>155</volume>
                  <fpage>338</fpage>
                  <lpage>347</lpage>
                  <pub-id pub-id-type="pmid">11441423</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Stine1">
                <label>52</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Stine</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Krystal</surname>
                      <given-names>JH</given-names>
                    </name>
                    <name>
                      <surname>Petrakis</surname>
                      <given-names>IL</given-names>
                    </name>
                    <name>
                      <surname>Jatlow</surname>
                      <given-names>PI</given-names>
                    </name>
                    <name>
                      <surname>Heninger</surname>
                      <given-names>GR</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>1997</year>
                  <article-title>Effect of alpha-methyl-para-tyrosine on response to cocaine challenge.</article-title>
                  <source>Biol Psychiatry</source>
                  <volume>42</volume>
                  <fpage>181</fpage>
                  <lpage>190</lpage>
                  <pub-id pub-id-type="pmid">9232210</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Barrett1">
                <label>53</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Barrett</surname>
                      <given-names>SP</given-names>
                    </name>
                    <name>
                      <surname>Pihl</surname>
                      <given-names>RO</given-names>
                    </name>
                    <name>
                      <surname>Benkelfat</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Brunelle</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Young</surname>
                      <given-names>SN</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2008</year>
                  <article-title>The role of dopamine in alcohol self-administration in humans: individual differences.</article-title>
                  <source>Eur Neuropsychopharmacology</source>
                  <volume>18</volume>
                  <fpage>439</fpage>
                  <lpage>447</lpage>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Casey1">
                <label>54</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Casey</surname>
                      <given-names>KF</given-names>
                    </name>
                    <name>
                      <surname>Benkelfat</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Young</surname>
                      <given-names>SN</given-names>
                    </name>
                    <name>
                      <surname>Leyton</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <year>2006</year>
                  <article-title>Lack of effect of acute dopamine precursor depletion in nicotine-dependent smokers.</article-title>
                  <source>Eur Neuropsychopharmacology</source>
                  <volume>16</volume>
                  <fpage>512</fpage>
                  <lpage>520</lpage>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Leyton2">
                <label>55</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Leyton</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>aan het Rot</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Booij</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Baker</surname>
                      <given-names>GB</given-names>
                    </name>
                    <name>
                      <surname>Young</surname>
                      <given-names>SN</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2007</year>
                  <article-title>Mood-elevating effects of d-amphetamine and incentive salience: the effect of acute dopamine precursor depletion.</article-title>
                  <source>J Psychiatry Neurosci</source>
                  <volume>32</volume>
                  <fpage>129</fpage>
                  <lpage>136</lpage>
                  <pub-id pub-id-type="pmid">17353942</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Leyton3">
                <label>56</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Leyton</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Casey</surname>
                      <given-names>KF</given-names>
                    </name>
                    <name>
                      <surname>Delaney</surname>
                      <given-names>JS</given-names>
                    </name>
                    <name>
                      <surname>Kolivakis</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Benkelfat</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <year>2005</year>
                  <article-title>Cocaine craving, euphoria, and self-administration: A preliminary study of the effect of catecholamine precursor depletion.</article-title>
                  <source>Behav Neurosci</source>
                  <volume>119</volume>
                  <fpage>1619</fpage>
                  <lpage>1627</lpage>
                  <pub-id pub-id-type="pmid">16420164</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Leyton4">
                <label>57</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Leyton</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Young</surname>
                      <given-names>SN</given-names>
                    </name>
                    <name>
                      <surname>Blier</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Baker</surname>
                      <given-names>GB</given-names>
                    </name>
                    <name>
                      <surname>Pihl</surname>
                      <given-names>RO</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2000</year>
                  <article-title>Acute tyrosine depletion and alcohol ingestion in healthy women.</article-title>
                  <source>Alcohol Clin Exp Res</source>
                  <volume>24</volume>
                  <fpage>459</fpage>
                  <lpage>464</lpage>
                  <pub-id pub-id-type="pmid">10798581</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Venugopalan1">
                <label>58</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Venugopalan</surname>
                      <given-names>VV</given-names>
                    </name>
                    <name>
                      <surname>Casey</surname>
                      <given-names>KF</given-names>
                    </name>
                    <name>
                      <surname>O'Hara</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>O'Loughlin</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Benkelfat</surname>
                      <given-names>C</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2011</year>
                  <article-title>Acute phenylalanine/tyrosine depletion reduces motivation to smoke across stages of addiction.</article-title>
                  <source>Neuropsychopharmacology</source>
                  <volume>36</volume>
                  <fpage>2469</fpage>
                  <lpage>2476</lpage>
                  <pub-id pub-id-type="pmid">21775977</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Acheson1">
                <label>59</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Acheson</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>de Wit</surname>
                      <given-names>H</given-names>
                    </name>
                  </person-group>
                  <year>2008</year>
                  <article-title>Bupropion improves attention but does not affect impulsive behavior in healthy young adults.</article-title>
                  <source>Exp Clin Psychopharmacol</source>
                  <volume>16</volume>
                  <fpage>113</fpage>
                  <lpage>123</lpage>
                  <pub-id pub-id-type="pmid">18489015</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-deWit1">
                <label>60</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>de Wit</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Enggasser</surname>
                      <given-names>JL</given-names>
                    </name>
                    <name>
                      <surname>Richards</surname>
                      <given-names>JB</given-names>
                    </name>
                  </person-group>
                  <year>2002</year>
                  <article-title>Acute administration of d-amphetamine decreases impulsivity in healthy volunteers.</article-title>
                  <source>Neuropsychopharmacology</source>
                  <volume>27</volume>
                  <fpage>813</fpage>
                  <lpage>825</lpage>
                  <pub-id pub-id-type="pmid">12431855</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Hamidovic1">
                <label>61</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hamidovic</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Dlugos</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Skol</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Palmer</surname>
                      <given-names>AA</given-names>
                    </name>
                    <name>
                      <surname>de Wit</surname>
                      <given-names>H</given-names>
                    </name>
                  </person-group>
                  <year>2009</year>
                  <article-title>Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: an exploratory study with d-amphetamine in healthy participants.</article-title>
                  <source>Exp Clin Psychopharmacol</source>
                  <volume>17</volume>
                  <fpage>374</fpage>
                  <lpage>383</lpage>
                  <pub-id pub-id-type="pmid">19968402</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Leyton5">
                <label>62</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Leyton</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <year>2009</year>
                  <article-title>The neurobiology of desire: Dopamine and the regulation of mood and motivational states in humans.</article-title>
                  <person-group person-group-type="editor">
                    <name>
                      <surname>Kringelbach M</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Berridge K</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <source>Pleasures of the Brain</source>
                  <publisher-loc>New York</publisher-loc>
                  <publisher-name>Oxford University Press</publisher-name>
                  <fpage>222</fpage>
                  <lpage>243</lpage>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Willner1">
                <label>63</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Willner</surname>
                      <given-names>P</given-names>
                    </name>
                  </person-group>
                  <year>1985</year>
                  <article-title>Depression: A Psychobiological Synthesis.</article-title>
                  <publisher-loc>New York</publisher-loc>
                  <publisher-name>John Wiley &amp; Sons</publisher-name>
                  <size units="page">597</size>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Treadway1">
                <label>64</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Treadway</surname>
                      <given-names>MT</given-names>
                    </name>
                    <name>
                      <surname>Zald</surname>
                      <given-names>DH</given-names>
                    </name>
                  </person-group>
                  <year>2011</year>
                  <article-title>Reconsidering anhedonia in depression: Lessons from translational neuroscience.</article-title>
                  <source>Neurosci Biobehav Rev</source>
                  <volume>35</volume>
                  <fpage>537</fpage>
                  <lpage>555</lpage>
                  <pub-id pub-id-type="pmid">20603146</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Salamone2">
                <label>65</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Salamone</surname>
                      <given-names>JD</given-names>
                    </name>
                    <name>
                      <surname>Correa</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Farrar</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Mingote</surname>
                      <given-names>SM</given-names>
                    </name>
                  </person-group>
                  <year>2007</year>
                  <article-title>Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits.</article-title>
                  <source>Psychopharmacology</source>
                  <volume>191</volume>
                  <fpage>461</fpage>
                  <lpage>482</lpage>
                  <pub-id pub-id-type="pmid">17225164</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Berridge4">
                <label>66</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Berridge</surname>
                      <given-names>KC</given-names>
                    </name>
                  </person-group>
                  <year>2007</year>
                  <article-title>The debate over dopamine's role in reward: The case for incentive salience.</article-title>
                  <source>Psychopharmacology</source>
                  <volume>191</volume>
                  <fpage>391</fpage>
                  <lpage>431</lpage>
                  <pub-id pub-id-type="pmid">17072591</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Ashby1">
                <label>67</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ashby</surname>
                      <given-names>FG</given-names>
                    </name>
                    <name>
                      <surname>Isen</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Turken</surname>
                      <given-names>AU</given-names>
                    </name>
                  </person-group>
                  <year>1999</year>
                  <article-title>A neuropsychological theory of positive affect and its influence on cognition.</article-title>
                  <source>Psychol Rev</source>
                  <volume>106</volume>
                  <fpage>529</fpage>
                  <lpage>550</lpage>
                  <pub-id pub-id-type="pmid">10467897</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Burgdorf1">
                <label>68</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Burgdorf</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Panksepp</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <year>2006</year>
                  <article-title>The neurobiology of positive emotions.</article-title>
                  <source>Neurosci Biobehav Rev</source>
                  <volume>30</volume>
                  <fpage>173</fpage>
                  <lpage>187</lpage>
                  <pub-id pub-id-type="pmid">16099508</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Wise4">
                <label>69</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wise</surname>
                      <given-names>RA</given-names>
                    </name>
                  </person-group>
                  <year>2008</year>
                  <article-title>Dopamine and reward: The anhedonia hypothesis 30 years on.</article-title>
                  <source>Neurotox Res</source>
                  <volume>14</volume>
                  <fpage>169</fpage>
                  <lpage>183</lpage>
                  <pub-id pub-id-type="pmid">19073424</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Rothman1">
                <label>70</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rothman</surname>
                      <given-names>RB</given-names>
                    </name>
                    <name>
                      <surname>Baumann</surname>
                      <given-names>MH</given-names>
                    </name>
                    <name>
                      <surname>Dersch</surname>
                      <given-names>CM</given-names>
                    </name>
                    <name>
                      <surname>Romero</surname>
                      <given-names>DV</given-names>
                    </name>
                    <name>
                      <surname>Rice</surname>
                      <given-names>KC</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2001</year>
                  <article-title>Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin.</article-title>
                  <source>Synapse</source>
                  <volume>39</volume>
                  <fpage>32</fpage>
                  <lpage>41</lpage>
                  <pub-id pub-id-type="pmid">11071707</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Pecina1">
                <label>71</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pecina</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>KS</given-names>
                    </name>
                    <name>
                      <surname>Berridge</surname>
                      <given-names>KC</given-names>
                    </name>
                  </person-group>
                  <year>2006</year>
                  <article-title>Hedonic hot spots in the brain.</article-title>
                  <source>Neuroscientist</source>
                  <volume>12</volume>
                  <fpage>500</fpage>
                  <lpage>511</lpage>
                  <pub-id pub-id-type="pmid">17079516</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Richard1">
                <label>72</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Richard</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Berridge</surname>
                      <given-names>KC</given-names>
                    </name>
                  </person-group>
                  <year>2011</year>
                  <article-title>Metabotropic glutamate receptor blockade in nucleus accumbens shell shifts affective valence towards fear and disgust.</article-title>
                  <source>Eur J Neurosci</source>
                  <volume>33</volume>
                  <fpage>736</fpage>
                  <lpage>747</lpage>
                  <pub-id pub-id-type="pmid">21198990</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Young1">
                <label>73</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Young</surname>
                      <given-names>SN</given-names>
                    </name>
                    <name>
                      <surname>Leyton</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <year>2002</year>
                  <article-title>The role of serotonin in human mood and social interaction. Insight from altered tryptophan levels.</article-title>
                  <source>Pharmacol Biochem Behav</source>
                  <volume>71</volume>
                  <fpage>857</fpage>
                  <lpage>865</lpage>
                  <pub-id pub-id-type="pmid">11888576</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Setiawan1">
                <label>74</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Setiawan</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Pihl</surname>
                      <given-names>RO</given-names>
                    </name>
                    <name>
                      <surname>Cox</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Gianoulakis</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Palmour</surname>
                      <given-names>RM</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2011</year>
                  <article-title>The effect of naltrexone on alcohol's stimulant properties and self-administration behavior in social drinkers: Influence of gender and genotype.</article-title>
                  <source>Alcohol Clin Exp Res</source>
                  <volume>35</volume>
                  <fpage>1</fpage>
                  <lpage>8</lpage>
                  <pub-id pub-id-type="pmid">20958327</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Mahler1">
                <label>75</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mahler</surname>
                      <given-names>SV</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>KS</given-names>
                    </name>
                    <name>
                      <surname>Berridge</surname>
                      <given-names>KC</given-names>
                    </name>
                  </person-group>
                  <year>2007</year>
                  <article-title>Endocannabinoid hedonic hotspot for sensory pleasure: Anandamide in nucleus accumbens shell enhances ‘liking’ of a sweet reward.</article-title>
                  <source>Neuropsychopharmacology</source>
                  <volume>32</volume>
                  <fpage>2267</fpage>
                  <lpage>2278</lpage>
                  <pub-id pub-id-type="pmid">17406653</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Salamone3">
                <label>76</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Salamone</surname>
                      <given-names>JD</given-names>
                    </name>
                    <name>
                      <surname>Correa</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Farrar</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Nunes</surname>
                      <given-names>EJ</given-names>
                    </name>
                    <name>
                      <surname>Pardo</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <year>2009</year>
                  <article-title>Dopamine, behavioral economics, and effort.</article-title>
                  <source>Front Behav Neurosci</source>
                  <volume>3</volume>
                  <fpage>13</fpage>
                  <pub-id pub-id-type="pmid">19826615</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Eisenegger1">
                <label>77</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Eisenegger</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Knoch</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Ebstein</surname>
                      <given-names>RP</given-names>
                    </name>
                    <name>
                      <surname>Gianotti</surname>
                      <given-names>LR</given-names>
                    </name>
                    <name>
                      <surname>Sandor</surname>
                      <given-names>PS</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2010</year>
                  <article-title>Dopamine receptor D4 polymorphism predicts the effect of L-DOPA on gambling behavior.</article-title>
                  <source>Biol Psychiatry</source>
                  <volume>67</volume>
                  <fpage>702</fpage>
                  <lpage>706</lpage>
                  <pub-id pub-id-type="pmid">19914604</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Floel1">
                <label>78</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Floel</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Garraux</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Xu</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Breitenstein</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Knecht</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2008</year>
                  <article-title>Levodopa increases memory encoding and dopamine release in the striatum in the elderly.</article-title>
                  <source>Neurobiol Aging</source>
                  <volume>29</volume>
                  <fpage>267</fpage>
                  <lpage>279</lpage>
                  <pub-id pub-id-type="pmid">17098331</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Pine1">
                <label>79</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pine</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Shiner</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Seymour</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Dolan</surname>
                      <given-names>RJ</given-names>
                    </name>
                  </person-group>
                  <year>2010</year>
                  <article-title>Dopamine, time, and impulsivity in humans.</article-title>
                  <source>J Neurosci</source>
                  <volume>30</volume>
                  <fpage>8888</fpage>
                  <lpage>8896</lpage>
                  <pub-id pub-id-type="pmid">20592211</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Kumakura1">
                <label>80</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kumakura</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Danielsen</surname>
                      <given-names>EH</given-names>
                    </name>
                    <name>
                      <surname>Reilhac</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Gjedde</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Cumming</surname>
                      <given-names>P</given-names>
                    </name>
                  </person-group>
                  <year>2004</year>
                  <article-title>Levodopa effect on [18F]fluorodopa influx to brain: Normal volunteers and patients with Parkinson's disease.</article-title>
                  <source>Acta Neurol Scand</source>
                  <volume>110</volume>
                  <fpage>188</fpage>
                  <lpage>195</lpage>
                  <pub-id pub-id-type="pmid">15285777</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Rodriguez1">
                <label>81</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rodriguez</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Morales</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Gonzalez-Mora</surname>
                      <given-names>JL</given-names>
                    </name>
                    <name>
                      <surname>Gomez</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Sabate</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2007</year>
                  <article-title>Different levodopa actions on the extracellular dopamine pools in the rat striatum.</article-title>
                  <source>Synapse</source>
                  <volume>61</volume>
                  <fpage>61</fpage>
                  <lpage>71</lpage>
                  <pub-id pub-id-type="pmid">17117421</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Raftopoulos1">
                <label>82</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Raftopoulos</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Dethy</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Laute</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Goldman</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Naini</surname>
                      <given-names>AB</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>1996</year>
                  <article-title>Slow increase of homovanillic acid in cerebrospinal fluid after levodopa administration.</article-title>
                  <source>Movement Disorders</source>
                  <volume>11</volume>
                  <fpage>59</fpage>
                  <lpage>62</lpage>
                  <pub-id pub-id-type="pmid">8771068</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-delaFuenteFernandez1">
                <label>83</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>de la Fuente-Fernandez</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Sossi</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Furtado</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Lu</surname>
                      <given-names>JQ</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2004</year>
                  <article-title>Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: Implications for dyskinesias.</article-title>
                  <source>Brain</source>
                  <volume>127</volume>
                  <fpage>2747</fpage>
                  <lpage>2754</lpage>
                  <pub-id pub-id-type="pmid">15329355</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Evans2">
                <label>84</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Evans</surname>
                      <given-names>AH</given-names>
                    </name>
                    <name>
                      <surname>Pavese</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Lawrence</surname>
                      <given-names>AD</given-names>
                    </name>
                    <name>
                      <surname>Tai</surname>
                      <given-names>YF</given-names>
                    </name>
                    <name>
                      <surname>Appel</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2006</year>
                  <article-title>Compulsive drug use linked to sensitized ventral striatal dopamine transmission.</article-title>
                  <source>Ann Neurology</source>
                  <volume>59</volume>
                  <fpage>852</fpage>
                  <lpage>858</lpage>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Steeves1">
                <label>85</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Steeves</surname>
                      <given-names>TDL</given-names>
                    </name>
                    <name>
                      <surname>Miyasaki</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Zurowski</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Lang</surname>
                      <given-names>AE</given-names>
                    </name>
                    <name>
                      <surname>Pellechia</surname>
                      <given-names>G</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2009</year>
                  <article-title>Increased striatal dopamine release in Parkinsonian patients with pathological gambling: A [<sup>11</sup>C]raclopride PET study.</article-title>
                  <source>Brain</source>
                  <volume>132</volume>
                  <fpage>1376</fpage>
                  <lpage>1385</lpage>
                  <pub-id pub-id-type="pmid">19346328</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-First1">
                <label>86</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>First</surname>
                      <given-names>MB</given-names>
                    </name>
                    <name>
                      <surname>Spitzer</surname>
                      <given-names>RI</given-names>
                    </name>
                    <name>
                      <surname>Gibbon</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <year>1995</year>
                  <article-title>Axis I Disorders.</article-title>
                  <publisher-loc>New York</publisher-loc>
                  <publisher-name>New York State Psychiatric Institute</publisher-name>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Dreher1">
                <label>87</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dreher</surname>
                      <given-names>JC</given-names>
                    </name>
                    <name>
                      <surname>Schmidt</surname>
                      <given-names>PJ</given-names>
                    </name>
                    <name>
                      <surname>Kohn</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Furman</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Rubinow</surname>
                      <given-names>D</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2007</year>
                  <article-title>Menstrual cycle phase modulates reward-related neural function in women.</article-title>
                  <source>Proc Natl Acad Sci U S A</source>
                  <volume>104</volume>
                  <fpage>2465</fpage>
                  <lpage>2470</lpage>
                  <pub-id pub-id-type="pmid">17267613</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Evans3">
                <label>88</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Evans</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Haney</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Foltin</surname>
                      <given-names>RW</given-names>
                    </name>
                  </person-group>
                  <year>2002</year>
                  <article-title>The effects of smoked cocaine during the follicular and luteal phases of the menstrual cycle in women.</article-title>
                  <source>Psychopharmacology (Berl)</source>
                  <volume>159</volume>
                  <fpage>397</fpage>
                  <lpage>406</lpage>
                  <pub-id pub-id-type="pmid">11823892</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Sofuoglu1">
                <label>89</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sofuoglu</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Dudish-Poulsen</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Nelson</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Pentel</surname>
                      <given-names>PR</given-names>
                    </name>
                    <name>
                      <surname>Hatsukami</surname>
                      <given-names>DK</given-names>
                    </name>
                  </person-group>
                  <year>1999</year>
                  <article-title>Sex and menstrual cycle differences in the subjective effects from smoked cocaine in humans.</article-title>
                  <source>Exp Clin Psychopharmacol</source>
                  <volume>7</volume>
                  <fpage>274</fpage>
                  <lpage>283</lpage>
                  <pub-id pub-id-type="pmid">10472516</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Cloninger1">
                <label>90</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cloninger</surname>
                      <given-names>CR</given-names>
                    </name>
                  </person-group>
                  <year>1987</year>
                  <article-title>A systematic method for clinical description and classification of personality variants. A proposal.</article-title>
                  <source>Arch Gen Psychiatry</source>
                  <volume>44</volume>
                  <fpage>573</fpage>
                  <lpage>588</lpage>
                  <pub-id pub-id-type="pmid">3579504</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Woicik1">
                <label>91</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Woicik</surname>
                      <given-names>PA</given-names>
                    </name>
                    <name>
                      <surname>Stewart</surname>
                      <given-names>SH</given-names>
                    </name>
                    <name>
                      <surname>Pihl</surname>
                      <given-names>RO</given-names>
                    </name>
                    <name>
                      <surname>Conrod</surname>
                      <given-names>PJ</given-names>
                    </name>
                  </person-group>
                  <year>2009</year>
                  <article-title>The Substance Use Risk Profile Scale: A scale measuring traits linked to reinforcement-specific substance use profiles.</article-title>
                  <source>Addict Behav</source>
                  <volume>34</volume>
                  <fpage>1042</fpage>
                  <lpage>1055</lpage>
                  <pub-id pub-id-type="pmid">19683400</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Costa1">
                <label>92</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Costa</surname>
                      <given-names>PT</given-names>
                    </name>
                    <name>
                      <surname>McCrae</surname>
                      <given-names>RR</given-names>
                    </name>
                  </person-group>
                  <year>1992</year>
                  <article-title>The Revised NEO Personality Inventory (NEO-PI-R) Professional Manual.</article-title>
                  <publisher-loc>Odessa, Florida</publisher-loc>
                  <publisher-name>Psycho-logical Assessment Resources</publisher-name>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Lorr1">
                <label>93</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lorr</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>McNair</surname>
                      <given-names>DM</given-names>
                    </name>
                    <name>
                      <surname>Fisher</surname>
                      <given-names>SU</given-names>
                    </name>
                  </person-group>
                  <year>1982</year>
                  <article-title>Evidence for bipolar mood states.</article-title>
                  <source>J Pers Assess</source>
                  <volume>46</volume>
                  <fpage>432</fpage>
                  <lpage>436</lpage>
                  <pub-id pub-id-type="pmid">7120016</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Lorr2">
                <label>94</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lorr</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>McNair</surname>
                      <given-names>DM</given-names>
                    </name>
                  </person-group>
                  <year>1988</year>
                  <article-title>Manual for the profile of mood states - bipolar form.</article-title>
                  <publisher-loc>San Diego, California</publisher-loc>
                  <publisher-name>Educational and Industrial Testing Service</publisher-name>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Blin1">
                <label>95</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Blin</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>Durup</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Pailhous</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Serratrice</surname>
                      <given-names>G</given-names>
                    </name>
                  </person-group>
                  <year>1990</year>
                  <article-title>Akathisia, motility, and locomotion in healthy volunteers.</article-title>
                  <source>Clin Neuropharmacol</source>
                  <volume>13</volume>
                  <fpage>426</fpage>
                  <lpage>435</lpage>
                  <pub-id pub-id-type="pmid">2272022</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Morcom1">
                <label>96</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Morcom</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Bullmore</surname>
                      <given-names>ET</given-names>
                    </name>
                    <name>
                      <surname>Huppert</surname>
                      <given-names>FA</given-names>
                    </name>
                    <name>
                      <surname>Lennox</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Praseedom</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2010</year>
                  <article-title>Memory encoding and dopamine in the aging brain: A psychopharmacological neuroimaging study.</article-title>
                  <source>Cereb Cortex</source>
                  <volume>20</volume>
                  <fpage>743</fpage>
                  <lpage>757</lpage>
                  <pub-id pub-id-type="pmid">19625385</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Micallef1">
                <label>97</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Micallef</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Rey</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Eusebio</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Audebert</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Rouby</surname>
                      <given-names>F</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2009</year>
                  <article-title>Antiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled study of L-dopa, bromocriptine and pramipexole in healthy subjects.</article-title>
                  <source>Br J Clin Pharmacol</source>
                  <volume>67</volume>
                  <fpage>333</fpage>
                  <lpage>340</lpage>
                  <pub-id pub-id-type="pmid">19220275</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Franken1">
                <label>98</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Franken</surname>
                      <given-names>IH</given-names>
                    </name>
                    <name>
                      <surname>Nijs</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Pepplinkhuizen</surname>
                      <given-names>L</given-names>
                    </name>
                  </person-group>
                  <year>2008</year>
                  <article-title>Effects of dopaminergic modulation on electrophysiological brain response to affective stimuli.</article-title>
                  <source>Psychopharmacology (Berl)</source>
                  <volume>195</volume>
                  <fpage>537</fpage>
                  <lpage>546</lpage>
                  <pub-id pub-id-type="pmid">17891382</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Cools1">
                <label>99</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cools</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Sheridan</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Jacobs</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>D'Esposito</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <year>2007</year>
                  <article-title>Impulsive personality predicts dopamine-dependent changes in frontostriatal activity during component processes of working memory.</article-title>
                  <source>J Neurosci</source>
                  <volume>27</volume>
                  <fpage>5506</fpage>
                  <lpage>5514</lpage>
                  <pub-id pub-id-type="pmid">17507572</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-RoeschEly1">
                <label>100</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Roesch-Ely</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Scheffel</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Weiland</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Schwaninger</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Hundemer</surname>
                      <given-names>HP</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2005</year>
                  <article-title>Differential dopaminergic modulation of executive control in healthy subjects.</article-title>
                  <source>Psychopharmacology (Berl)</source>
                  <volume>178</volume>
                  <fpage>420</fpage>
                  <lpage>430</lpage>
                  <pub-id pub-id-type="pmid">15765257</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Mehta1">
                <label>101</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mehta</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Swainson</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Ogilvie</surname>
                      <given-names>AD</given-names>
                    </name>
                    <name>
                      <surname>Sahakian</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Robbins</surname>
                      <given-names>TW</given-names>
                    </name>
                  </person-group>
                  <year>2001</year>
                  <article-title>Improved short-term spatial memory but impaired reversal learning following the dopamine D(2) agonist bromocriptine in human volunteers.</article-title>
                  <source>Psychopharmacology (Berl)</source>
                  <volume>159</volume>
                  <fpage>10</fpage>
                  <lpage>20</lpage>
                  <pub-id pub-id-type="pmid">11797064</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Abduljawad1">
                <label>102</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Abduljawad</surname>
                      <given-names>KA</given-names>
                    </name>
                    <name>
                      <surname>Langley</surname>
                      <given-names>RW</given-names>
                    </name>
                    <name>
                      <surname>Bradshaw</surname>
                      <given-names>CM</given-names>
                    </name>
                    <name>
                      <surname>Szabadi</surname>
                      <given-names>E</given-names>
                    </name>
                  </person-group>
                  <year>1998</year>
                  <article-title>Effects of bromocriptine and haloperidol on prepulse inhibition of the acoustic startle response in man.</article-title>
                  <source>J Psychopharmacology</source>
                  <volume>12</volume>
                  <fpage>239</fpage>
                  <lpage>245</lpage>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Muller1">
                <label>103</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Muller</surname>
                      <given-names>U</given-names>
                    </name>
                    <name>
                      <surname>von Cramon</surname>
                      <given-names>DY</given-names>
                    </name>
                    <name>
                      <surname>Pollmann</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <year>1998</year>
                  <article-title>D1- versus D2-receptor modulation of visuospatial working memory in humans.</article-title>
                  <source>J Neurosci</source>
                  <volume>18</volume>
                  <fpage>2720</fpage>
                  <lpage>2728</lpage>
                  <pub-id pub-id-type="pmid">9502829</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Andreu1">
                <label>104</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Andreu</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Chale</surname>
                      <given-names>JJ</given-names>
                    </name>
                    <name>
                      <surname>Senard</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Thalamas</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Montastruc</surname>
                      <given-names>JL</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>1999</year>
                  <article-title>L-Dopa-induced sedation: a double-blind cross-over controlled study versus triazolam and placebo in healthy volunteers.</article-title>
                  <source>Clin Neuropharmacol</source>
                  <volume>22</volume>
                  <fpage>15</fpage>
                  <lpage>23</lpage>
                  <pub-id pub-id-type="pmid">10047929</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-vanderPost1">
                <label>105</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>van der Post</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>de Waal</surname>
                      <given-names>PP</given-names>
                    </name>
                    <name>
                      <surname>de Kam</surname>
                      <given-names>ML</given-names>
                    </name>
                    <name>
                      <surname>Cohen</surname>
                      <given-names>AF</given-names>
                    </name>
                    <name>
                      <surname>van Gerven</surname>
                      <given-names>JMA</given-names>
                    </name>
                  </person-group>
                  <year>2004</year>
                  <article-title>No evidence of the usefulness of eye blinking as a marker for central dopaminergic activity.</article-title>
                  <source>J Psychopharmacology</source>
                  <volume>18</volume>
                  <fpage>109</fpage>
                  <lpage>114</lpage>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Breitenstein1">
                <label>106</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Breitenstein</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Korsukewitz</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Floel</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Kretzschmar</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Diederich</surname>
                      <given-names>K</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2006</year>
                  <article-title>Tonic dopaminergic stimulation impairs associative learning in healthy subjects.</article-title>
                  <source>Neuropsychopharmacology</source>
                  <volume>31</volume>
                  <fpage>2552</fpage>
                  <lpage>2564</lpage>
                  <pub-id pub-id-type="pmid">16880771</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Upadhyaya1">
                <label>107</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Upadhyaya</surname>
                      <given-names>HP</given-names>
                    </name>
                    <name>
                      <surname>Brady</surname>
                      <given-names>KT</given-names>
                    </name>
                    <name>
                      <surname>Liao</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Sethuraman</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Middaugh</surname>
                      <given-names>L</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2003</year>
                  <article-title>Neuroendocrine and behavioral responses to dopaminergic agonists in adolescents with alcohol abuse.</article-title>
                  <source>Psychopharmacology (Berl)</source>
                  <volume>166</volume>
                  <fpage>95</fpage>
                  <lpage>101</lpage>
                  <pub-id pub-id-type="pmid">12520313</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Hamidovic2">
                <label>108</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hamidovic</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Kang</surname>
                      <given-names>UJ</given-names>
                    </name>
                    <name>
                      <surname>de Wit</surname>
                      <given-names>H</given-names>
                    </name>
                  </person-group>
                  <year>2008</year>
                  <article-title>Effects of low to moderate acute doses of pramipexole on impulsivity and cognition in healthy volunteers.</article-title>
                  <source>J Clin Psychopharmacol</source>
                  <volume>28</volume>
                  <fpage>45</fpage>
                  <lpage>51</lpage>
                  <pub-id pub-id-type="pmid">18204340</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Pizzagalli1">
                <label>109</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pizzagalli</surname>
                      <given-names>DA</given-names>
                    </name>
                    <name>
                      <surname>Evins</surname>
                      <given-names>AE</given-names>
                    </name>
                    <name>
                      <surname>Schetter</surname>
                      <given-names>EC</given-names>
                    </name>
                    <name>
                      <surname>Frank</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <name>
                      <surname>Pajtas</surname>
                      <given-names>PE</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2008</year>
                  <article-title>Single dose of a dopamine agonist impairs reinforcement learning in humans: Behavioral evidence from a laboratory-based measure of reward responsiveness.</article-title>
                  <source>Psychopharmacology (Berl)</source>
                  <volume>196</volume>
                  <fpage>221</fpage>
                  <lpage>232</lpage>
                  <pub-id pub-id-type="pmid">17909750</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Roussos1">
                <label>110</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Roussos</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Giakoumaki</surname>
                      <given-names>SG</given-names>
                    </name>
                    <name>
                      <surname>Bitsios</surname>
                      <given-names>P</given-names>
                    </name>
                  </person-group>
                  <year>2009</year>
                  <article-title>Tolcapone effects on gating, working memory, and mood interact with the synonymous catechol-O-methyltransferase rs4818c/g polymorphism.</article-title>
                  <source>Biol Psychiatry</source>
                  <volume>66</volume>
                  <fpage>997</fpage>
                  <lpage>1004</lpage>
                  <pub-id pub-id-type="pmid">19699472</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Giakoumaki1">
                <label>111</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Giakoumaki</surname>
                      <given-names>SG</given-names>
                    </name>
                    <name>
                      <surname>Roussos</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Bitsios</surname>
                      <given-names>P</given-names>
                    </name>
                  </person-group>
                  <year>2008</year>
                  <article-title>Improvement of prepulse inhibition and executive function by the COMT inhibitor tolcapone depends on COMT Val158Met polymorphism.</article-title>
                  <source>Neuropsychopharmacology</source>
                  <volume>33</volume>
                  <fpage>3058</fpage>
                  <lpage>3068</lpage>
                  <pub-id pub-id-type="pmid">18536698</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0028370-Apud1">
                <label>112</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Apud</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>Mattay</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Kolachana</surname>
                      <given-names>BS</given-names>
                    </name>
                    <name>
                      <surname>Callicott</surname>
                      <given-names>JH</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2007</year>
                  <article-title>Tolcapone improves cognition and cortical information processing in normal human subjects.</article-title>
                  <source>Neuropsychopharmacology</source>
                  <volume>32</volume>
                  <fpage>1011</fpage>
                  <lpage>1020</lpage>
                  <pub-id pub-id-type="pmid">17063156</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
